The Manitowoc Company, Inc. (MTW) 10-K 22 Feb 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Jan. 31, 2022	Jun. 30, 2021
Cover [Abstract]
Entity Registrant Name	The Manitowoc Company, Inc.
Entity Central Index Key	0000061986
Trading Symbol	MTW
Document Type	10-K
Document Period End Date	Dec. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	true
Entity Public Float			$ 840.8
Entity Shares Outstanding		35,056,252
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity File Number	1-11978
Entity Tax Identification Number	39-0448110
Entity Address, Address Line One	11270 West Park Place
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53224
City Area Code	414
Local Phone Number	760-4600
Entity Incorporation, State or Country Code	WI
Title of 12(b) Security	Common Stock, $.01 Par Value
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for the 2022 Annual Meeting of Shareholders, are incorporated by reference in Part III of this Annual Report on Form 10-K
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Milwaukee, Wisconsin
Auditor Firm ID	238

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net sales	$ 1,720.2	$ 1,443.4	$ 1,834.1
Cost of sales	1,413	1,188.7	1,490
Gross profit	307.2	254.7	344.1
Operating costs and expenses:
Engineering, selling and administrative expenses	258.5	208.8	225.6
Asset impairment expense	1.9	0	0
Amortization of intangible assets	1.4	0.3	0.3
Restructuring (income) expense	(1.1)	7	9.8
Total operating costs and expenses	260.7	216.1	235.7
Operating income (loss)	46.5	38.6	108.4
Other income (expense):
Interest expense	(28.9)	(29.1)	(32.7)
Amortization of deferred financing fees	(1.5)	(1.5)	(1.5)
Loss on debt extinguishment	0	0	(25)
Other income (expense) — net	1	(10)	9.8
Total other expense - net	(29.4)	(40.6)	(49.4)
Income (loss) before income taxes	17.1	(2)	59
Provision (benefit) for income taxes	6.1	17.1	12.4
Net income (loss)	$ 11	$ (19.1)	$ 46.6
Per Share Data
Basic income (loss) per common share	$ 0.32	$ (0.55)	$ 1.31
Diluted income (loss) per share	$ 0.31	$ (0.55)	$ 1.31

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 11	$ (19.1)	$ 46.6
Other comprehensive income (loss), net of income tax:
Unrealized gains (losses) on derivatives, net of income tax			0.3
Employee pension and postretirement benefit income (expense), net of income tax	15.6	(8)	(3.7)
Foreign currency translation adjustments	(20.5)	31.5	(1)
Total other comprehensive income (loss), net of income tax	(4.9)	23.5	(4.4)
Comprehensive income	$ 6.1	$ 4.4	$ 42.2

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on derivatives, net of income tax provision	$ 0	$ 0	$ 0
Employee pension and post retirement benefits costs, net of income tax benefit (provision)	(0.4)	0.6	0.2
Foreign currency translation adjustments, net of income tax provision (benefit)	$ 5.1	$ (4.6)	$ 0

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 75.4	$ 128.7
Accounts receivable, less allowances of $. and $8.5, respectively	236.1	215.1
Inventories — net	576.8	473.1
Notes receivable — net	16.7	13.6
Other current assets	36.8	35.5
Total current assets	941.8	866
Property, plant and equipment — net	358.8	294.3
Operating lease right-of-use assets	40.6	37.9
Goodwill	249.7	235.1
Other intangible assets — net	139.6	121.6
Other non-current assets	44.7	48.6
Total assets	1,775.2	1,603.5
Current Liabilities:
Accounts payable and accrued expenses	413.4	329.4
Short-term borrowings and current portion of long-term debt	7.3	10.5
Product warranties	49	50.2
Customer advances	28.7	25.5
Other liabilities	22.6	20.2
Total current liabilities	521	435.8
Non-Current Liabilities:
Long-term debt	399.9	300.4
Operating lease liabilities	29.2	28.4
Deferred income taxes	6.5	5.9
Pension obligations	69.4	89.3
Postretirement health and other benefit obligations	12.1	14
Long-term deferred revenue	22.9	32.4
Other non-current liabilities	51.8	53.8
Total non-current liabilities	591.8	524.2
Commitments and contingencies (Note 19)
Total stockholders' equity:
Preferred stock (3,500,000 shares authorized of $.01 par value; none outstanding)	0	0
Common stock (75,00,000 shares authorized, 40,793,983 shares issued, 35,056,252 and 34,580,638 shares outstanding, respectively)	0.4	0.4
Additional paid-in capital	602.4	595.1
Accumulated other comprehensive loss	(102.4)	(97.5)
Retained earnings	227.9	216.9
Treasury stock, at cost ( 5,737,731 and 6,213,345 shares, respectively)	(65.9)	(71.4)
Total stockholders’ equity	662.4	643.5
Total liabilities and stockholders' equity	$ 1,775.2	$ 1,603.5

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accounts Receivable, allowances (in dollars)	$ 7.3	$ 8.5
Preferred stock authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	40,793,983	40,793,983
Common stock, shares outstanding (in shares)	35,056,252	34,580,638
Treasury stock (in shares)	5,737,731	6,213,345

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash Flows From Operating Activities
Net income (loss)	$ 11	$ (19.1)	$ 46.6
Adjustments to reconcile net income (loss) to cash provided by (used for -)operating activities:
Asset impairment expense	1.9	0	0
Depreciation expense	45.5	37.2	35
Amortization of intangible assets	1.4	0.3	0.3
Amortization of deferred financing fees	1.5	1.5	1.5
Deferred income tax (benefit) - net	(0.6)	4.8	1.5
Loss on early extinguishment of debt	0	0	25
Loss (gain) on sale of property, plant and equipment	0.2	0	(3.5)
Net unrealized foreign currency transaction losses	0.7	3.6	7.5
Stock-based compensation expense	7.1	6	9.5
Other	3.2	0.5	0.6
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(5.2)	(37.7)	(124.2)
Inventories	(68.3)	8.3	(18.3)
Notes receivable	1	7.4	2.9
Other assets	(7.6)	(7.1)	16.4
Accounts payable	62.9	(20.1)	(59.7)
Accrued expenses and other liabilities	20.3	(20.7)	5.6
Net cash used for operating activities	76.2	(35.1)	(53.3)
Cash Flows From Investing Activities
Capital expenditures	(40.4)	(26.3)	(35.1)
Proceeds from sale of fixed assets	0.3	0.5	17.2
Acquisition of business (Note 9)	(186.2)	0	0
Cash receipts on sold accounts receivable	0	0	126.3
Net cash provided by (used for) investing activities	(226.3)	(25.8)	108.4
Cash Flows From Financing Activities
Proceeds from revolving credit facility	100	50	139.7
Payments on revolving credit facility	0	(50)	(139.7)
Payments on long-term debt	0	0	(276.6)
Proceeds from long-term debt	0	0	300
Other debt - net	(4.9)	(2.9)	(4.4)
Debt issuance costs	0	0	(8.3)
Exercises of stock options including windfall tax benefits	5.8	0.1	0.4
Common stock repurchases	0	(12)	(7.4)
Net cash provided by (used for) financing activities	100.9	(14.8)	3.7
Effect of exchange rate changes on cash	(4.1)	5.1	0.2
Net increase (decrease) in cash and cash equivalents	(53.3)	(70.6)	59
Cash and cash equivalents at beginning of period	128.7	199.3	140.3
Cash and cash equivalents at end of period	75.4	128.7	199.3
Supplemental Cash Flow Information
Interest paid	28.9	28.8	36
Income taxes (paid) refunded	$ 3.7	$ (13.6)	$ (10.5)

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Retained EarningsCumulative Effect Period Of Adoption Adjustment	Treasury Stock
Balance at beginning of year at Dec. 31, 2018		$ 0.4	$ 584.8	$ (116.6)	$ 189.6		$ (56.9)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(2.1)				2.4
Common stock repurchases							(7.4)
Stock-based compensation			9.5
Other comprehensive income (loss)				(4.4)
Net income (loss)	$ 46.6				46.6
Balance at end of year at Dec. 31, 2019	645.9	0.4	592.2	(121)	236.2	$ (0.2)	(61.9)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(3.1)				2.5
Common stock repurchases							(12)
Stock-based compensation			6
Other comprehensive income (loss)				23.5
Net income (loss)	(19.1)				(19.1)
Balance at end of year at Dec. 31, 2020	643.5	0.4	595.1	(97.5)	216.9		(71.4)
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			0.2				5.5
Stock-based compensation			7.1
Other comprehensive income (loss)				(4.9)
Net income (loss)	11				11
Balance at end of year at Dec. 31, 2021	$ 662.4	$ 0.4	$ 602.4	$ (102.4)	$ 227.9		$ (65.9)

Company and Basis of Presentati

Company and Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Company and Basis of Presentation	1. Company and Basis of Presentation The Manitowoc Company, Inc. (“Manitowoc” and the “Company”) was founded in 1902 and has over a 119-year tradition of providing high-quality, customer-focused products and support services to its markets. Manitowoc is one of the world's leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain and Shuttlelift brand names. The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure and residential construction end markets. Additionally, the Company leverages its installed base of approximately 155,000 cranes to provide aftermarket parts and services to enable its customers to manage their fleets more effectively and improve their return on investment. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc’s aftermarket support operations provide the Company with a consistent stream of recurring revenue. The Company continues to expand its tower crane rental fleet in the EURAF segment to directly serve its customers in the region. Manitowoc is a Wisconsin corporation and its principal executive offices are located at 11270 West Park Place Suite 1000, Milwaukee, Wisconsin 53224. Basis of Presentation The consolidated financial statements include the accounts of The Manitowoc Company, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. All amounts, except share and per share amounts, are in millions throughout the tables in these notes unless otherwise indicated. Certain prior period amounts have been reclassified to conform to the current period presentation. All amounts, except share and per share amounts, are in millions throughout the tables in these notes unless otherwise indicated. Impact of the COVID-19 Pandemic During 2020, the COVID-19 pandemic significantly impacted demand for the Company’s products which subsided in 2021. However, the Company experienced, and is still experiencing, supply chain and logistic constraints that negatively impacted its ability to manufacture and ship products. In addition, the Company experienced inflationary cost pressures which have negatively impacted its results.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents. Allowance for Doubtful Accounts Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. The Company's estimate for the allowance for doubtful accounts is based on an estimate of the losses inherent in amounts billed, pools of receivables with similar risk characteristics, existing and future economic conditions, reasonable and supportable forecasts that affect the collectability of the related receivable and any specific customer collection issues the Company has identified. The following table is a rollforward of the allowance for doubtful accounts for the years ended December 31, 2021 and 2020. 2021 2020 Balance at beginning of period $ 8.5 $ 7.9 Bad debt expenses — 3.6 Use of reserve ( 1.3 ) ( 2.7 ) Currency translation 0.1 ( 0.3 ) Balance at end of period $ 7.3 $ 8.5 Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out method. Business Combinations The Company accounts for business combinations under the acquisition method in accordance with Accounting Standards Codification ("ASC") Topic 805, Business Combinations ("Topic 805"). The acquisition method requires identifiable assets acquired and liabilities assumed and any non-controlling interest in the business acquired be recognized and measured at fair value on the acquisition date, which is the date that the Company obtains control of the acquired business. The amount by which the fair value of consideration transferred as the purchase price exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The Company expenses transaction costs in a business combination. Goodwill and Other Intangible Assets The Company accounts for goodwill and other intangible assets under the guidance of ASC Topic 350-10, “Intangibles — Goodwill and Other” ("Topic 350"). Under ASC Topic 350, goodwill is not amortized; instead, the Company performs an annual impairment review. The date for the annual impairment review is October 31, 2021 or more frequently if events or changes in circumstances indicate that the assets might be impaired. To perform its goodwill impairment review, the Company uses the income approach and market approach with a weighting of 70/30, respectively, to fair value each reporting unit. If the carrying amount exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of the goodwill. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value. The Company’s other intangible assets with indefinite lives, are not amortized but are tested for impairment annually, or more frequently, as events dictate. For other indefinite lived intangible assets, the impairment test consists of a comparison of the fair value of the intangible assets to their carrying amount. See Note 10, “Goodwill and Other Intangible Assets,” for further details on our impairment assessments. The Company’s intangible assets subject to amortization are tested for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable. The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives: Useful lives Patents 20 years Customer relationships 12 - 18 years Trademarks and tradenames 5 years Noncompetition agreements 5 years Other intangibles 9 months Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance, repairs and minor renewals are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and depreciated over the remaining estimated useful life. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the asset’s estimated useful life using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes. Property, plant and equipment are depreciated over the following estimated useful lives: Years Building and improvements 2 - 43 Machinery, equipment and tooling 3 - 18 Furniture and fixtures 3 - 10 Computer hardware and software 3 - 10 Rental cranes 5 - 15 Property, plant and equipment also includes cranes accounted for as operating leases. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer at the time of the order had a significant economic incentive to exercise. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of buyback and rental equipment included in property, plant and equipment amounted to $ 119.5 million and $ 59.9 million, net of accumulated depreciation, as of December 31, 2021 and 2020, respectively. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If an impairment is determined to exist, any related impairment loss is calculated based upon comparison of the expected undiscounted future cash flows to the net book value of the assets. Warranties Estimated manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs during the extended warranty period are expensed as incurred. Product Liabilities The Company records product liability reserves for its self-insured portion of any outstanding product liability cases when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates. Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC Topic 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge. The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates. The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes. Stock-Based Compensation The Company recognizes expense net of estimated future forfeitures for all stock-based compensation on a straight-line basis over the vesting period of the entire award. Estimated future forfeitures are based on the Company’s historical experience. Stock-based compensation plans are described more fully in Note 17, “Stock-Based Compensation.” Research and Development Research and development costs are charged to expense as incurred and amounted to $ 29.1 million, $ 30.6 million and $ 31.1 million for the years ended December 31, 2021, 2020 and 2019 , respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs. Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority. Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted net income (loss) per share reflects the effect of all potential dilutive shares that were outstanding during the respective periods, unless the effect of doing so would be antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards. Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net income (loss) , other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments. Net Sales Sales are recognized when obligations under the terms of a contract with the Company’s customer are satisfied; generally this occurs with the transfer of control of the Company’s cranes or aftermarket parts or completion of performance of services. Sales are measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. The Company recognizes sales for extended warranties over the life of the extended warranty period. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from sales. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are categorized as a fulfillment cost and are included in cost of sales on the Consolidated Statement of Operations. Performance Obligations The following is a description of principle activities from which the Company generates sales. Disaggregation of the Company’s revenue sources are disclosed in Note 18, “Segments.” Crane Sales Crane sales are primarily generated through the sale of new and used cranes. Contracts with customers are generally in the form of a purchase order. Based on the nature of the Company’s contracts, the Company does not have any significant financing terms. Contracts may have variable consideration in the form of early pay discounts or rebates, however variable consideration is not material to the overall contract with the customer. Sales are earned under these contracts when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier or acceptance through an independent inspection company that acts as an agent of the customer. From time to time, the Company enters into agreements where the customer has the right to exercise a put option requiring the Company to buyback a crane at an agreed upon price. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise that right. If it is determined that the customer has a significant economic incentive to exercise that right, the agreement is accounted for as a lease in accordance with ASC Topic 842 “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the asset is transferred to the customer. Refer to Note 20, “Guarantees” for additional information. Given the nature of the Company’s products, the customer may request that the product be held until a delivery location is identified. Under these “bill and hold” arrangements, sales are recognized when all of the following criteria are met: 1) the reason for the bill-and-hold arrangement is substantive, 2) the product is separately identified as belonging to the customer, 3) the product is ready for transfer to the customer, and 4) the Company does not have the ability to use the product or direct it to another customer. Aftermarket Part Sales Aftermarket part sales are generated through the sale of new and used parts to end customers and distributors. Aftermarket part sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Customers generally have a right of return which the Company estimates using historical information. The amount of estimated returns is deducted from net sales. Other Sales The Company’s other sales consist primarily of sales from: • Repair and field service work; • Rental of cranes; and • Training and technical publications. The Company’s performance obligations for other sales generally relates to performing specific agreed upon services. Sales are earned upon the completion of those services. Practical Expedients and Exemptions The Company expenses sales commissions when incurred because the amortization period would be one year or less. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. Recent Accounting Changes and Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 “Income Taxes (Topic 740).” The amendments in this ASU simplify accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The standard is effective for annual periods beginning after December 15, 2020. The adoption of ASU 2019-02 did not have a material impact on the Company’s consolidated financial statements.

Business Combinations

Business Combinations	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Business Combinations	3. Business Combinations Acquisition of Aspen Equipment Company On September 1, 2021, the Company completed the acquisition of substantially all of the assets of Aspen Equipment Company ("Aspen"), a diversified crane dealer and a leading final stage purpose built work truck upfitter for a purchase price of approximately $ 50.2 million. The acquisition of Aspen was funded from existing cash resources and expands Manitowoc's direct-to-customer footprint in Iowa, Nebraska and Minnesota with new sales, used sales, parts, service and rentals to a variety of end markets. Included in the purchase price was $ 12.9 million of net working capital, $ 6.0 million of property, plant and equipment, $ 19.3 million of rental fleet, $ 0.4 million of other assets, $ 6.2 million of goodwill and $ 5.4 million of intangible assets. Refer to Note 10, "Goodwill and Other Intangible Assets," for additional information on the class of intangibles acquired and goodwill recorded. The purchase price allocation is subject to the completion of final valuation of the net assets acquired. The financial results of Aspen from September 1, 2021 are included in the Company's consolidated financial statements and are reported in the Americas segment. The amount of revenue and income from operations associated with the acquisition from the acquisition date to December 31, 2021 did not have a material impact on the consolidated financial statements. Pro-forma financial information has not been provided as the acquisition did not have a material impact on the Consolidated Statements of Operations. Acquisition of H&E Crane Business On October 1, 2021, the Company completed the acquisition of substantially all of the assets and certain liabilities of the crane business of H&E Equipment Services, Inc. (“H&E”) for a transaction price of approximately $ 139.1 million which is inclusive of the purchase price of $ 130.0 million, working capital and other adjustments of $ 5.9 million and settlement of outstanding balances between the Company and the acquired company of $ 3.2 million. The purchase price is subject to customary adjustments for, among other things, finalization of net working capital and other transaction adjustments. The acquisition was funded from existing cash resources, including the use of the ABL revolver of which $ 100.0 million was outstanding as of December 31, 2021. The H&E crane business operates with ten full-service branch locations under the Company's new wholly owned subsidiary, MGX Equipment Services, LLC ("MGX"), and expands Manitowoc’s ability to provide new sales, used sales, aftermarket parts, service and crane financing options to a variety of end market customers. The purchase price was allocated to underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of the combination as follows: Net working capital $ 50.0 Property, plant and equipment 13.1 Rental fleet 48.2 Goodwill 8.9 Noncompetition agreement intangible 3.8 Customer relationships intangible 15.1 Total fair value consideration $ 139.1 The financial results of the H&E crane business from October 1, 2021 are included in the Company's consolidated financial statements and are reported in the Americas segment. The amount of revenue on a standalone basis generated by the acquisition from October 1, 2021 to December 31, 2021 was $ 50.6 million, $ 7.6 million net of previously recorded third-party sales. The amount of earnings associated with the acquisition from October 1, 2021 through December 31, 2021 was immaterial to the Company's Consolidated Statement of Operations. Pro-forma financial information has not been provided as the acquisition did not have a material impact on the Consolidated Statements of Operations.

Net Sales

Net Sales	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Net Sales	4. Net Sales The Company defers revenue when cash payments are received in advance of satisfying the related performance obligation. The amounts are recorded as customer advances in the Consolidated Balance Sheets. The table below shows the change in the customer advances balance for the year ended December 31, 2021 and 2020. 2021 2020 Balance at beginning of period $ 25.5 $ 25.8 Cash received in advance of satisfying 128.4 108.0 Revenue recognized ( 124.5 ) ( 108.5 ) Currency translation ( 0.7 ) 0.2 Balance at end of period $ 28.7 $ 25.5 Disaggregation of the Company's revenue sources are disclosed in Note 18, "Segments."

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	5. Fair Value of Financial Instruments ASC Topic 820-10 ("ASC 820") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability The following tables sets forth the Company’s financial assets and liabilities related to FX Forward Contracts that were accounted for at fair value as of December 31, 2021 and 2020. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Fair Value as of December 31, 2021 Level 1 Level 2 Level 3 Total Recognized Location FX Forward Contracts $ — $ 0.3 $ — $ 0.3 Accounts payable and accrued expenses Fair Value as of December 31, 2020 Level 1 Level 2 Level 3 Total Recognized Location FX Forward Contracts $ — $ — $ — $ — Other current assets FX Forward Contracts $ — $ — $ — $ — Accounts payable and accrued expenses The fair value of the senior secured second lien notes due on April 1, 2026 , with an annual coupon rate of 9.000 % (the “2026 Notes”), was approximately $ 317.8 million as of December 31, 2021. See Note 12, "Debt," for a description of the 2026 Notes and the related carrying value. The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates the fair value of its 2026 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash equivalents, accounts receivable, accounts payable and short-term variable debt, including any amounts outstanding under the Company's revolving credit facility, approximate fair value, without being discounted as of December 31, 2021 due to the short-term nature of these instruments. FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. See Note 6, “Derivative Financial Instruments” for additional information.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	6. Derivative Financial Instruments The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks. From time to time, the Company enters into FX Forward Contracts to manage the currency risks associated with forecasted transactions and assets/liabilities denominated in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in AOCI. These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to forecasted transactions no longer being probable during the years ended December 31, 2021, 2020 and 2019. The Company had FX Forward Contracts with an aggregate notional amount of $ 11.3 million and $ 9.3 million ou tstanding as of December 31, 2021 and 2020, respectively. The aggregate notional amount outstanding as of December 31, 2021 is scheduled to mature within one year . The FX Forward Contracts purchased are denominated in various foreign currencies. As of December 31, 2021 and 2020, the net fair value of these contracts was a net short term liability of $ 0.3 million and zero, respectively . Net unrealized gains (losses), net of income tax, recorded in AOCI were zero as o f December 31, 2021 and 2020. The gains (losses) recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2021 and 2020 are summarized as follows: Recognized Location 2021 2020 2019 Designated Cost of sales $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Non-Designated Other income (expense) - net 0.4 0.6 3.9

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	7. Inventories The components of inventories as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Raw materials $ 157.4 $ 89.6 Work-in-process 140.4 102.3 Finished goods 279.0 281.2 Total Inventories — net $ 576.8 $ 473.1

Notes Receivable

Notes Receivable	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Notes Receivable	8. Notes Receivable The Company's notes receivable balances are classified as current or long-term based on the timing of amounts due. Long-term notes receivable is included within other non-current assets in the Consolidated Balance Sheet. Current and long-term notes receivable balances primarily relate to the Company's captive finance entity in China and entity in Mexico. The Company had a long-term note receivable balance related to the 2014 sale of Manitowoc Dong Yue. In 2021, the Company recorded $ 3.6 million of expense in engineering, selling and administrative expenses in the Consolidated Statement of Operations to fully reserve for the remaining net value of the note with Manitowoc Dong Yue. As of December 31, 2021, the Company had current and long-term notes receivable in the amounts of $ 16.7 million and $ 5.2 million, respectively. As of December 31, 2020, the Company had current and long-term notes receivable in the amounts of $ 13.6 million and $ 12.7 million, respectively.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	9. Property, Plant and Equipment The components of property, plant and equipment as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Land $ 19.4 $ 20.3 Building and improvements 203.4 203.7 Machinery, equipment and tooling 298.9 292.6 Furniture and fixtures 14.5 21.0 Computer hardware and software 125.6 119.3 Rental cranes 144.2 90.2 Construction in progress 15.1 9.0 Total cost 821.1 756.1 Less accumulated depreciation ( 462.3 ) ( 461.8 ) Property, plant and equipment — net $ 358.8 $ 294.3 Assets Held for Sale As of December 31, 2021 and 2020 the Company had $ 3.1 million and $ 3.3 million , respectively, classified as other current assets in the Consolidated Balance Sheets. These amounts relate to a manufacturing building and land in Fanzeres, Portugal that are held for sale. Asset Impairment During the year ended December 31, 2021, the Company recorded an asset impairment of $ 1.9 million to write-down the value of one of the Company's Brazil entities to its expected sale price. The Company recorded no asset impairment charges for the year ended December 31, 2020 .

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	10. Goodwill and Other Intangible Assets The Company performs its annual goodwill and indefinite lived assets impairment testing during the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired. A considerable amount of management judgment and assumptions are required in performing the impairment tests as it relates to revenue growth rates and projected operating income. While the Company believes the judgments and assumptions are reasonable, different assumptions could change the estimated fair value and, therefore, additional impairment charges could be required. Weakening industry or economic trends, disruptions to our business, unexpected significant changes or planned changes in the use of the assets or in entity structure may adversely impact the assumptions used in the valuations. The Company continually monitors market conditions and determines if any additional interim reviews of goodwill, other intangibles or long-lived assets are warranted. In the event the Company determines that assets are impaired in the future, the Company would recognize a non-cash impairment charge, which could have a material adverse effect on the Company’s Consolidated Balance Sheets and Results of Operations. The Company has four reporting units, Americas - Manufacturing, Americas - Distribution, EURAF and MEAP. The changes in carrying amount of goodwill for the years ended December 31, 2021 and 2020 are as follows: Americas - Manufacturing Americas - Distribution MEAP Consolidated Balance as of January 1, 2020 $ 166.5 $ — $ 66.0 $ 232.5 Foreign currency impact — — 2.6 2.6 Net balance as of December 31, 2020 166.5 — 68.6 235.1 Foreign currency impact — — ( 0.5 ) ( 0.5 ) Acquisitions — 15.1 — 15.1 Net balance as of December 31, 2021 $ 166.5 $ 15.1 $ 68.1 $ 249.7 During the year, the Company recorded goodwill of approximately $ 6.2 million from the acquisition of Aspen and $ 8.9 million from the acquisition of H&E's crane business. Management determined the goodwill represents the assembled workforce and synergies between the acquired companies and Manitowoc that are not individually identified and separately recognized. Goodwill related to the acquisitions are subject to change as part of the completion of acquisition accounting. The total goodwill related to the acquisitions is deductible for tax purposes over 15 years. Refer to Note 3, "Business Combinations," for additional information. The gross carrying amount, accumulated amortization and net book value of the Company’s intangible assets other than goodwill as of December 31, 2021 and 2020 are summarized as follows: December 31, 2021 December 31, 2020 Gross Accumulated Net Gross Accumulated Net Definite lived intangible assets: Customer relationships $ 27.0 $ ( 9.0 ) $ 18.0 $ 9.9 $ ( 8.6 ) $ 1.3 Patents 29.7 ( 29.1 ) 0.6 31.0 ( 30.3 ) 0.7 Noncompetition agreements 4.2 ( 0.4 ) 3.8 — — — Trademarks and tradenames 2.2 ( 0.1 ) 2.1 — — — Other intangibles 0.6 ( 0.2 ) 0.4 — — — Total 63.7 ( 38.8 ) 24.9 40.9 ( 38.9 ) 2.0 Indefinite lived intangible assets: Trademarks and tradenames 95.9 — 95.9 100.0 — 100.0 Distribution network 18.8 — 18.8 19.6 — 19.6 Total 114.7 — 114.7 119.6 — 119.6 Total other intangible assets $ 178.4 $ ( 38.8 ) $ 139.6 $ 160.5 $ ( 38.9 ) $ 121.6 Amortization of intangible assets for the years ended December 31, 2021, 2020 and 2019 was $ 1.4 million, $ 0.3 million and $ 0.3 million, respectively. Excluding the impact of any future acquisitions, divestitures or impairments, the Company's anticipated future amortization of intangible assets as of December 31, 2021 is as follows: Year 2022 $ 3.3 2023 2.9 2024 2.9 2025 2.9 2026 2.7 Thereafter 10.1 Total $ 24.8 As a result of the acquisition of Aspen during the year ending December 31, 2021, intangible assets of approximately $ 2.2 million for customer relationships, $ 2.2 million for tradenames, $ 0.8 million for other intangibles and $ 0.2 million for a noncompetition agreement was acquired. The useful life for each intangible asset class is 18 years, 5 years, 9 months and 5 years, respectively. The weighted average useful life for acquired intangibles is 3.2 years. The fair value of identifiable intangible assets has been determined using the income approach which involves significant unobservable inputs. The allocation of purchase price to intangible assets is subject to change upon completion of acquisition accounting. As a result of the acquisition of H&E's crane business during the year ending December 31, 2021, intangible assets of approximately $ 15.1 million for customer relationships and $ 3.8 million for a noncompetition agreement was acquired. The useful life for each intangible asset class is 12 years and 5 years, respectively. The weighted average useful life for the acquired intangibles is 9.4 years. The fair value of identifiable intangible assets has been determined using the income approach which involves significant unobservable inputs. The allocation of purchase price to intangible assets is subject to change upon completion of acquisition accounting. Definite lived intangible assets and long-lived assets are subject to impairment testing whenever events or circumstances indicate that the carrying value of the assets may not be recoverable. The Company determined there was not a triggering event during the year ended December 31, 2021 .

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	11. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Trade accounts payable $ 238.8 $ 178.1 Employee-related expenses 51.9 38.5 Accrued vacation 22.2 22.4 Miscellaneous accrued expenses 100.5 90.4 Total accounts payable and accrued expenses $ 413.4 $ 329.4

Debt

Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Debt	12. Debt Outstanding debt as of December 31, 2021 and 2020 is summarized as follows: 2021 2020 Borrowing under senior secured asset based revolving $ 100.0 $ — 2026 Notes 300.0 300.0 Other 10.3 14.7 Deferred financing costs ( 3.1 ) ( 3.8 ) Total debt 407.2 310.9 Short-term borrowings and current portion of ( 7.3 ) ( 10.5 ) Long-term debt $ 399.9 $ 300.4 On March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $ 275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2026 Notes and the related guarantees. The ABL Revolving Credit Facility has a term of five years and includes a $ 75.0 million letter of credit sub-facility, $ 10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility. On June 17, 2021 the Company amended its ABL Credit Agreement to adjust certain negative covenants reducing restrictions on the Company's ability to expand its rental business. Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or the Eurodollar and Overnight London Interbank Offered Rate (“LIBOR”). The variable interest rate is based upon the average availability as of the most recent determination date as follows: Average quarterly availability Alternative base rate spread Eurodollar and overnight LIBOR spread ≥ 50% of Aggregate Commitment 0.25 % 1.25 % < 50% of Aggregate Commitment 0.50 % 1.50 % As of December 31, 2021, the Company had outstanding $ 10.3 million of other indebtedness that has a weighted-average interest rate of approximately 3.4 % . This debt includes balances on local credit lines and other financing arrangements. As of December 31, 2021, the Company had $ 100.0 million of borrowings outstanding under the ABL Revolving Credit Facility and no borrowings outstanding as of December 31, 2020. During the year ended December 31, 2021, the highest daily borrowing under the ABL Revolving Credit Facility was $ 100.0 million and the average borrowing was $ 26.0 million, while the weighted-average annual interest rate was 1.4 % . During the year ended Dec ember 31, 2020, the highest daily borrowing under the ABL Revolving Credit Facility was $ 50.0 million and the average borrowing was $ 13.3 million, while the weighted-average annual interest rate was 1.8 %. The interest rate of the ABL Revolving Credit Facility fluctuates based on excess availability. During the year ended December 31, 2021, the spreads for LIBOR and Eurodollar, and Alternative Base Rate borrowings were 1.25 % and 0.25 %, respectively. Excess availability as of December 31, 2021 was $ 136.3 million, which represents revolver borrowing capacity of $ 239.3 million less $ 100.0 million in borrowings outstanding and U.S. letters of credit outstanding of $ 3.0 million. On March 25, 2019, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank National Association as trustee and notes collateral agent, pursuant to which the Company issued $ 300.0 million aggregate principal amount of the 2026 Notes with an annual coupon rate of 9.000 %. Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year. The 2026 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility or that guarantees certain other debt of the Company or a guarantor. The 2026 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions and permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility. Both the ABL Revolving Credit Facility and the 2026 Notes include customary covenants which include, without limitation, restrictions on, the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2026 Notes also include customary events of default. The ABL Revolving Credit Facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in the Company’s business or financial condition since December 31, 2018. Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement. The aggregate scheduled future maturities of outstanding debt obligations as of December 31, 2021 is as follows: Year 2022 $ 7.3 2023 1.4 2024 101.5 2025 0.1 2026 300.0 Thereafter — Total $ 410.3 • The table of scheduled maturities above does not agree to the Company’s total debt as of December 31, 2021 as shown on the Consolidated Balance Sheet due to $ 3.1 million of deferred financing costs. As of December 31, 2021 , the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months

Accounts Receivable Factoring

Accounts Receivable Factoring	12 Months Ended
	Dec. 31, 2021
Transfers and Servicing [Abstract]
Accounts Receivable Factoring	13. Accounts Receivable Factoring The Company has two non-U.S. accounts receivable financing programs with maximum availability of € 55.0 million and one U.S. accounts receivable financing program with maximum availability of $ 40.5 million. Under these financing programs, the Company has the ability to sell eligible receivables up to the maximum limit and can sell additional receivables as previously sold receivables are collected. As of the year ended December 31, 2021, the Company sold receivables and received cash of $ 228.6 million. Transactions under the U.S. and non-U.S. accounts receivable financing programs are accounted for as sales in accordance with ASC Topic 860.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	14. Income Taxes Income (loss) before income taxes for the years ended December 31, 2021, 2020 and 2019 is summarized as follows: 2021 2020 2019 Income (loss) before income taxes: U.S. $ ( 39.0 ) $ ( 51.6 ) $ ( 10.0 ) Non-U.S. 56.1 49.6 69.0 Total $ 17.1 $ ( 2.0 ) $ 59.0 Income tax provision (benefit) for the years ended December 31, 2021, 2020 and 2019 is summarized as follows: 2021 2020 2019 Current: U.S. federal and state $ ( 1.2 ) $ ( 4.3 ) $ ( 0.7 ) Non-U.S. 7.9 16.6 11.6 Total current $ 6.7 $ 12.3 $ 10.9 Deferred: U.S. federal and state $ 0.6 $ 0.3 $ 0.2 Non-U.S. ( 1.2 ) 4.5 1.3 Total deferred $ ( 0.6 ) $ 4.8 $ 1.5 Income tax provision $ 6.1 $ 17.1 $ 12.4 The calculated U.S. federal income tax amount at the statutory rate of 21 % is reconciled to the Company’s income tax provision (benefit) for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 U.S. federal income tax at statutory rate $ 3.6 $ ( 0.4 ) $ 12.4 U.S. state income tax provision 0.3 1.9 ( 0.1 ) Manufacturing and research incentives ( 0.2 ) ( 0.8 ) ( 3.0 ) Taxes on non-U.S. income which differ from the U.S. 1.5 — ( 2.6 ) Adjustments for unrecognized tax benefits ( 2.3 ) 10.7 ( 1.3 ) Adjustments for valuation allowances 4.5 22.2 4.5 U.S. tax reform ( 1.6 ) ( 14.6 ) 4.0 Other items 0.3 ( 1.9 ) ( 1.5 ) Income tax provision $ 6.1 $ 17.1 $ 12.4 For the years ended December 31, 2021, 2020 and 2019, the Company recorded an income tax inclusion for the global intangible low-taxed income (“GILTI”) in the amount of $ 2.5 million, zero and $ 22.7 million, respectively, which is fully offset by the valuation allowance recorded in the U.S. The GILTI inclusion for each respective year is reflective of the final regulations issued in 2020 relating to Internal Revenue Code Section 951A and the treatment of foreign income subject to a high tax rate. While effective beginning in 2021, the regulations allowed for retroactive application which the Company elected in the period of issuance for 2019 and 2020. In 2021, the Company filed an amended return to adopt the regulations for the 2018 tax year, resulting in a net income tax benefit of $ 1.6 million recorded for the year ended December 31, 2021. As of each reporting date, the Company considers new evidence, both positive and negative, that could impact management's assessment related to future realization of deferred tax assets. As of December 31, 2021, the Company has recorded valuation allowances on the deferred tax assets for certain legal entities in Brazil, China, Germany, India, U.K. and the U.S. as it is more likely than not that the assets will not be realized. The 2021 income tax provision includes a $ 2.7 million income tax benefit for the partial valuation allowance release in China which is offset by a $ 6.9 million increase to the valuation allowance for other jurisdictions. The 2019 and 2020 income tax provisions were impacted by a net increase of $ 4.5 million and $ 22.2 million, respectively, related to additional valuation allowances recorded in various jurisdictions. The Company will continue to evaluate the realizability of its deferred tax assets and may adjust its valuation allowances based on changes in facts and circumstances. It is reasonably possible that the Company will either increase or decrease a portion of its existing valuation allowances in the future. Such changes in the realizability of deferred tax assets will be reflected in continuing operations and could have a material effect on operating results. During 2021, the only significant item included within the other items per the U.S. federal statutory reconciliation is a $ 1.9 million benefit relating to the French income tax refund as a result of a Mutually Agreed upon Procedure for 2006 between the Italian and French tax authorities. There were no significant items included in other items for 2020 and the only significant item included in the 2019 other items was the favorable resolution of the German income tax audit in the amount of $ 0.8 million. Temporary differences and carryforwards that give rise to deferred tax assets and liabilities include the following items: 2021 2020 Deferred income tax assets: Inventories $ 23.9 $ 22.8 Deferred employee benefits 30.8 34.7 Product warranty reserves 8.9 9.3 Product liability reserves 2.0 2.0 Tax credits 7.4 7.7 Loss and other tax attribute carryforwards 151.1 142.6 Deferred revenue 2.4 3.9 Other 20.6 18.0 Total deferred income tax assets 247.1 241.0 Less valuation allowance ( 170.5 ) ( 171.4 ) Net deferred income tax assets $ 76.6 $ 69.6 Deferred income tax liabilities Accounts receivable 1.5 2.7 Property, plant and equipment 23.0 17.2 Intangible assets 34.7 36.0 Total deferred income tax liabilities $ 59.2 $ 55.9 Net deferred income tax assets $ 17.4 $ 13.7 The net deferred tax assets reflected in the Consolidated Balance Sheets for the years ended December 31, 2021 and 2020 are as follows: 2021 2020 Long-term income tax assets, included in $ 23.9 $ 19.6 Long-term deferred income tax liability ( 6.5 ) ( 5.9 ) Net deferred income tax asset $ 17.4 $ 13.7 The Company believes that certain offshore cash can be accessed in a tax efficient manner and therefore, as of December 31, 2021, $ 0.8 million of deferred taxes were provided on approximately $ 245.5 million of unremitted earnings of non-U.S. subsidiaries that may be remitted to the U.S. As of December 31, 2020, $ 0.9 million of deferred taxes were provided on approximately $ 239.4 million of unremitted earnings of non-U.S. subsidiaries that may be remitted to the U.S. The Company has approximately $ 481.5 million of foreign earnings as of December 31, 2021 which are asserted to be permanently reinvested. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable. The Company has approximately $ 189.0 million of U.S. federal loss carryforwards, which are available to reduce future U.S. federal tax liabilities. $ 24.4 million of the federal net operating loss carryforward expire in 2036 and the remaining $ 164.6 million is not subject to any time restrictions for future use. However, utilization of these indefinite lived loss carryforwards is annually limited to 80 % of adjusted taxable income. The carryforward is offset by a valuation allowance. The Company has approximately $ 9.0 million of U.S. federal interest expense carryforwards that is not subject to any time restrictions for future use. The utilization of the interest expense carryforwards is annually limited to 30 % of adjusted taxable income. The carryforward is offset by a full valuation allowance. The Company has approximately $ 772.0 million of U.S. state net operating loss carryforwards, which are available to reduce future U.S. state tax liabilities. These U.S. state net operating loss carryforwards expire at various times through 2041 . The Company has recorded a full valuation allowance related to the U.S. state net operating losses. The Company has approximately $ 281.2 million of non-U.S. loss carryforwards, which are available to reduce future non-U.S. tax liabilities. Substantially all the non-U.S. loss carryforwards have an indefinite carryforward period of which $ 151.9 million are offset by a valuation allowance. The Company or one of its subsidiaries files income tax returns in the U.S. federal, U.S. state and non-U.S. jurisdictions. The following table provides the open tax years for which the Company could be subject to income tax examination by the tax authorities in its major jurisdictions: Jurisdiction Open Years U.S. federal 2016 — 2021 China 2012 — 2021 France 2019 — 2021 Germany 2018 — 2021 During 2021, the Company closed the audit with the German tax authorities for calendar years 2015 to 2017. There have been no significant developments with respect to the Company’s ongoing tax audits in other the U.S. federal, state and non-U.S. jurisdictions. The Company regularly assesses the likelihood of an adverse outcome resulting from examinations to determine the adequacy of its tax reserves. As of December 31, 2021, the Company believes that it is more likely than not that the tax positions it has taken will be sustained upon the resolution of its audits resulting in no material impact on its consolidated financial position and the results of operations and cashflows. However, the final determination with respect to any tax audits, including any related litigation, could be materially different from the Company’s accruals and could have a material effect on operating results and/or cashflows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties and/or interest assessments. During the years ended December 31, 2021, 2020 and 2019 , the Company recorded an increase (decrease) to the gross unrecognized tax benefits including interest and penalties of $( 2.1 ) million, $ 5.5 million and $ 1.7 million, respectively, of which $( 0.4 ) million, $( 3.1 ) million and $( 0.3 ) million, respectively, are a result of the net reductions to interest and penalties. As of December 31, 2021, 2020 and 2019 , the Company has accrued interest and penalties of $ 2.9 million, $ 3.3 million and $ 6.4 million, respectively. A reconciliation of the beginning and ending amount of unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2021, 2020 and 2019 is as follows: 2021 2020 2019 Balance at beginning of year $ 20.1 $ 11.5 $ 12.8 Additions for tax positions of current year 0.1 0.3 0.5 Additions for tax positions of prior years — 10.9 0.3 Reductions for tax positions of prior years ( 0.2 ) ( 0.4 ) — Reductions based on settlements with tax ( 0.2 ) ( 2.1 ) ( 0.6 ) Reductions for lapse of statute of limitations ( 1.4 ) ( 0.1 ) ( 1.5 ) Balance at end of year $ 18.4 $ 20.1 $ 11.5 The decrease in unrecognized tax benefits excluding interest and penalties primarily relates to $ 1.4 million of foreign reserves released due to the closing of statues of limitations. Approximately $ 14.0 million, $ 15.4 million and $ 7.2 million of the Company’s unrecognized tax benefits as of December 31, 2021, 2020 and 2019, respectively, would impact the effective tax rate. During the next twelve months, the unrecognized tax benefits are not expected to significantly increase or decrease because the Company’s tax positions are sustained on audit or settled, or the applicable statute of limitations closes.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	15. Net Income (Loss) Per Share The following is a reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per share: 2021 2020 2019 Basic weighted average common shares outstanding 34,903,189 34,691,063 35,487,358 Effect of dilutive securities - stock awards 549,366 — 154,442 Diluted weighted average common shares outstanding 35,452,555 34,691,063 35,641,800 Equity incentive instruments for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net earnings, and accordingly, are excluded from diluted weighted average common shares outstanding. Anti-dilutive equity instruments of 358,706 and 1,527,645 common shares were excluded from the computation of diluted net earnings per share for the years ended December 31, 2021 and 2019, respectively. Due to the net loss during the year ended December 31, 2020, the as sumed exercise of all equity incentive instruments was anti-dilutive and, therefore, not included in the diluted loss per share calculation for this period.

Equity

Equity	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Equity	16. Equity Authorized capitalization consists of 75.0 million shares of $ 0.01 par value common stock and 3.5 million shares of $ 0.01 par value preferred stock. None of the preferred shares have been issued. As of December 31, 2021, the Company had authorization from the Board of Directors to purchase up to $ 30.0 million of the Company’s common stock at management’s discretion. As of December 31, 2021, the Company has $ 10.6 m illion remaining under this authorization. The amount and timing of any dividends are determined by the Board of Directors at its regular meetings each year, subject to limitations within the indenture governing the Company’s 2026 Notes and the Company’s ABL Revolving Credit Facility. No cash dividends were declared or paid in the years ended December 31, 2021, 2020, and 2019. The components of accumulated other comprehensive loss as of December 31, 2021 and 2020 are as follows: 2021 2020 Foreign currency translation, net of income tax (provision) 0.6 and $( 4.6 ) $ ( 70.1 ) $ ( 49.6 ) Employee pension and postretirement benefit adjustments, 13.9 and $ 14.4 ( 32.3 ) ( 47.9 ) Total accumulated other comprehensive loss $ ( 102.4 ) $ ( 97.5 ) A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component as of December 31, 2020 and 2021 are as follows: Gains Pension & Foreign Total Balance as of December 31, 2019 $ — $ ( 39.9 ) $ ( 81.1 ) $ ( 121.0 ) Other comprehensive income (loss) before ( 0.3 ) ( 9.9 ) 31.5 21.3 Amounts reclassified from accumulated other 0.3 1.9 — 2.2 Net other comprehensive income (loss) — ( 8.0 ) 31.5 23.5 Balance as of December 31, 2020 — ( 47.9 ) ( 49.6 ) ( 97.5 ) Other comprehensive income (loss) before ( 1.1 ) 14.5 ( 20.5 ) ( 7.1 ) Amounts reclassified from accumulated other 1.1 1.1 — 2.2 Net other comprehensive income (loss) — 15.6 ( 20.5 ) ( 4.9 ) Balance as of December 31, 2021 $ — $ ( 32.3 ) $ ( 70.1 ) $ ( 102.4 ) A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2021, 2020 and 2019 are as follows: Amount Reclassified from Accumulated Other Comprehensive Loss 2021 2020 2019 Recognized Losses on cash flow hedges FX Forward Contracts $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Cost of sales Total before income taxes ( 1.1 ) ( 0.3 ) ( 3.1 ) Provision for income taxes — — — Total, net of income taxes $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Amortization of pension and Actuarial losses $ ( 4.7 ) $ ( 4.5 ) $ ( 4.6 ) (a) Other expense - net Amortization of prior service cost 2.6 2.6 2.8 (a) Other expense - net Pension settlement charge 0.9 — — (a) Other expense - net Total before income taxes ( 1.2 ) ( 1.9 ) ( 1.8 ) Benefit for income taxes 0.1 — — Total, net of income taxes $ ( 1.1 ) $ ( 1.9 ) $ ( 1.8 ) Total reclassifications for the period, net $ ( 2.2 ) $ ( 2.2 ) $ ( 4.9 ) (a) These accumulated other comprehensive loss components are components of net periodic pension cost (see Note 22, “Employee Benefit Plans,” for further details).

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	17. Stock-Based Compensation The Company’s 2013 Omnibus Incentive Plan (the “2013 Omnibus Plan”) was approved by shareholders on May 7, 2013 and replaced the 2003 Incentive Stock and Awards Plan (the “2003 Stock Plan”). The 2013 Omnibus Plan also replaced the Company’s Short-Term Incentive Plan (the “STIP”) as of December 31, 2013. The 2003 Stock Plan and the STIP are referred to cumulatively as the “Prior Plans.” No new awards may be granted under the Prior Plans after the respective termination dates, but the Prior Plans continue to govern awards outstanding issued thereunder; outstanding awards will continue in force and effect until vested, exercised or forfeited pursuant to their terms. The 2013 Omnibus Plan provides for both short-term and long-term incentive awards for employees and non-employee directors. Stock-based awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance share or performance unit awards. The total number of shares of the Company’s common stock available for awards under the 2013 Omnibus Plan is 7,477,395 s hares. The total number of shares of the Company’s common stock still available for issuance as of December 31, 2021 is 4,238,315 shares. The Company recognizes expense net of estimated future forfeitures for all stock-based compensation on a straight-line basis over the vesting period of the entire award. Estimated future forfeitures are based on the Company’s historical experience. During the year ended December 31, 2021, the Company recorded stock-based compensation expense of $ 7.1 million recorded in engineering, selling and administrative expense in the Consolidated Statement of Operations. During the year ended December 31, 2020 , the Company recorded stock-based compensation expense of $ 6.0 million of which $ 8.5 million was included in engineering, selling and administrative expense and $ 2.5 million of income was included in restructuring expense in the Consolidated Statement of Operations. Income recorded in restructuring expense was primarily related to the forfeiture of grants associated with employee separation agreements. Total stock-based compensation expense recognized within engineering, selling and administrative expenses in the Consolidated Statements of Operations $ 9.5 million during the year ended December 31, 2019. Shares are issued out of treasury stock upon exercise for stock options and vesting of restricted stock units and performance share units. Stock Options Stock option grants to employees are exercisable in three annual increments over a three-year period beginning on the first anniversary of the grant date and expire 10 years subsequent to the grant date. The Company did no t grant employees stock options in 2021. The Company granted stock options to employees to acquire 250,432 and 210,243 s hares of common stock during the years ended December 31, 2020 and 2019 , respectively. Stock-based compensation expense is calculated by estimating the fair value of non-qualified stock options at the time of grant and is amortized over the stock options’ vesting period. The Company recognized $ 0.6 million, $ 1.3 million and $ 2.7 million of expense before income taxes associated with stock options during 2021, 2020 and 2019, respectively. A summary of the Company’s stock option activity is as follows: Shares Weighted Aggregate Options outstanding as of December 31, 2020 1,067,880 $ 20.91 Granted — — Exercised ( 306,015 ) 19.50 Forfeited ( 1,327 ) 18.40 Cancelled ( 135,221 ) 24.79 Options outstanding as of December 31, 2021 625,317 $ 20.76 $ 1.0 Options exercisable as of December 31, 2021 509,911 $ 22.22 $ 0.5 The Company uses the Black-Scholes valuation model to value stock options. The Company’s volatility assumption was based on a blend of its historical stock price and an average of historical stock prices of selected peers. The assumed risk-free rate was based on U.S. Treasury rates in effect at the time of grant with varying maturities weighted commensurately with the expected life assumption. The expected option life represents the period of time options are expected to be outstanding and is based on historical experience. The weighted average fair value per share of options granted during the years ended December 31, 2020 and 2019 was $ 5.35 and $ 8.07 , respectively. T he fair value of each option grant was estimated at the date of grant using the following assumptions: 2020 2019 Expected life (years) 6.5 6.5 Risk-free interest rate 1.2 % 2.6 % Expected volatility 42.3 % 39.8 % Expected dividend yield — % — % As of December 31, 2021, the Company ha s $ 0.2 million of unrecognized compensation expense before income tax related to stock options, which will be recognized over a weighted average period of 1.0 years. Restricted Stock Units The Company granted 358,255 , 333,269 and 178,371 restricted stock units in 2021, 2020 and 2019, respectively. The Company recognized $ 3.7 million, $ 3.5 million and $ 2.4 million of compensation expense associated with restricted stock units during 2021, 2020 and 2019, respectively. The restricted stock units are earned based on service over the vesting period. Beginning in 2019, restrictions on restricted stock units granted to employees lapse in three annual increments over a three-year period beginning on the first anniversary of the grant date. Prior to 2019, restrictions on restricted stock units granted to employees lapse 100 % on the third anniversary of the grant date , assuming continued employment. The expense is based on the fair value of the Company's shares as of the grant date which is the grant date closing stock price. A summary of activity for restricted stock units is as follows: Shares Weighted Unvested as of December 31, 2020 362,293 $ 14.87 Granted 358,255 17.59 Vested ( 154,099 ) 17.36 Forfeited ( 14,793 ) 16.98 Unvested as of December 31, 2021 551,656 $ 15.89 As of December 31, 2021, the Company has $ 4.8 million of unrecognized compensation expense before income tax related to restricted stock units which will be recognized over a weighted average period of 2.0 years. Performance Share Units The Company granted 159,247 , 328,310 and 228,037 of performance share units in 2021, 2020 and 2019 , respectively. The performance share units are earned based on service over the vesting period and on the extent to which performance goals are met over the applicable three-year performance period. The performance goals vary for performance share units each grant year. The Company recognized $ 1.9 million , $ 0.2 million and $ 3.4 million of compensation expense associated with performance share units during 2021, 2020 and 2019, respectively. The performance goals for the performance share granted in 2021 are weighted 60 % on the 3-year average of the Company’s adjusted EBITDA percentage from 2021 to 2023 and 40 % on non-new machines sales as of the year ended December 31, 2023. The Company defines non-new machine sales as parts sales, used crane sales, rental revenue, service revenue and other revenue. The 2021 performance share include a +/- 20 % modifier weighted on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200 % of target shares granted. The performance share units granted in 2020 are earned based on the extent to which performance goals are met by the Company over a three-year period from January 1, 2020 to December 31, 2022. The performance goals for the performance share units granted in 2020 are based on the 3-year average of the Company’s adjusted EBITDA percentage from continuing operations from 2020 to 2022 with a +/- 20 % modifier based on total shareholder return relative to a defined peer group of companies during the three-year performance period, not to exceed 200 % of target shares granted. Depending on the forgoing factors, the number of shares earned could range from zero to two times the amount of performance share units outstanding on the vesting date. The performance share units granted in 2019 are earned based on the extent to which performance goals are met by the Company over a three-year period from January 1, 2019 to December 31, 2021. The performance goals were based fifty percent ( 50 %) on total shareholder return relative to a peer group of companies over the three-year period and fifty percent ( 50 %) on meeting targeted adjusted EBITDA margin at the end of the three-year period. Depending on the foregoing factors, the current number of shares awarded could range from zero to two times the amount of performance share units outstanding on the vesting date. A summary of activity for performance share units is as follows: Shares Weighted Unvested as of December 31, 2020 358,335 $ 18.64 Granted 159,247 18.92 Vested ( 5,825 ) 17.50 Forfeited ( 11,073 ) 17.25 Unvested as of December 31, 2021 500,684 $ 17.45 As of December 31, 2021, the Company has $ 3.0 million of unrecognized compensation expense before income tax related to performance share units which will be recognized over a weighted average period of 2.0 years. The expense for the adjusted EBITDA performance share units is based on the fair value of the Company's shares as of the grant date which is the grant date closing stock price. For total shareholder return performance share units, the Company uses the Monte Carlo valuation model to determine fair value of the grants. The Company used an average of historical stock prices of selected peers for its volatility assumption. The assumed risk-free rates were based on three-year U.S. Treasury rates in effect at the time of grant. The fair value of each total shareholder return performance share unit was estimated at the date of grant using the following assumptions: 2021 2020 2019 Correlation 27.9 % 32.2 % 32.5 % Risk-free interest rate 0.2 % 1.1 % 2.5 % Expected volatility 59.0 % 47.5 % 47.0 % Expected dividend yield — % — % — % Director Compensation Awards A total of 59,280 , 77,608 and 5 0,673 equity compensation awards were granted to directors in 2021, 2020 and 2019 respectively. The equity compensation awards vested immediately upon the grant date. The Company recognized $ 1.0 million of compensation expense associated with equity compensation awards to directors in each of the years ended December 31, 2021, 2020 and 2019 . The expense is based on the fair value of the Company's shares as of the grant date which is the grant date closing stock price.

Segments

Segments	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segments	18. Segments The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the CEO, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s reportable operating segments. The Company has three reportable segments: Americas, EURAF, and MEAP. The Americas operating segment includes the North America and South America continents. The EURAF operating segment includes the Europe and Africa continents, excluding the Middle East region. The MEAP operating segment includes the Asia and Australia continents and the Middle East region. The results of the acquired Aspen and MGX businesses are included in the Americas segment. The CODM evaluates the performance of its reportable segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, and operating expenses directly attributable to the segment. Manufacturing variances generated within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expenses, income taxes, nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The Company's operating segments were identified as its reporting segments. The CODM does not evaluate performance of the reportable segments based on total assets. The following table shows information by reportable segment for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Net Sales Americas $ 757.6 $ 626.1 $ 969.7 EURAF 677.0 598.7 644.9 MEAP 285.6 218.6 219.5 Total $ 1,720.2 $ 1,443.4 $ 1,834.1 Segment Operating Income Americas $ 57.3 $ 32.1 $ 113.4 EURAF 8.9 12.0 3.8 MEAP 30.9 30.4 22.6 Total $ 97.1 $ 74.5 $ 139.8 Depreciation Americas $ 20.7 $ 15.7 $ 14.5 EURAF 19.8 16.5 15.1 MEAP 2.1 2.1 2.4 Corporate 2.9 2.9 3.0 Total $ 45.5 $ 37.2 $ 35.0 Capital Expenditures Americas $ 11.3 $ 6.0 $ 13.2 EURAF 27.5 19.0 19.0 MEAP 1.5 1.2 2.9 Corporate 0.1 0.1 — Total $ 40.4 $ 26.3 $ 35.1 A reconciliation of the Company’s segment operating income to operating income in the Consolidated Statement of Operations for the years ended December 31, 2021, 2020 and 2019 is as follows: 2021 2020 2019 Segment operating income $ 97.1 $ 74.5 $ 139.8 Unallocated corporate expenses ( 51.1 ) ( 32.2 ) ( 31.3 ) Unallocated restructuring income (expense) 0.5 ( 3.7 ) ( 0.1 ) Total operating income $ 46.5 $ 38.6 $ 108.4 Net sales by geographic area for the years ended December 31, 2021, 2020 and 2019 and property, plant and equipment as of December 31, 2021 and 2020 are summarized as follows: Net Sales Property, Plant and Equipment 2021 2020 2019 2021 2020 United States $ 664.5 $ 564.9 $ 860.4 $ 163.3 $ 97.9 Europe 653.7 585.4 619.8 168.0 167.8 Other 402.0 293.1 353.9 27.5 28.6 Total $ 1,720.2 $ 1,443.4 $ 1,834.1 $ 358.8 $ 294.3 Net sales by product for the years ended December 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 New equipment sales $ 1,271.6 $ 1,067.1 $ 1,431.0 Non-new machine sales 448.6 376.3 403.1 Total net sales $ 1,720.2 $ 1,443.4 $ 1,834.1

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	19. Commitments and Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business which have not been fully resolved. The outcome of any litigation is inherently uncertain. When a loss related to a legal proceeding or claim is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter. As of December 31, 2021 , various product-related lawsuits were pending. To the extent permitted under applicable law, all of these are insured with self-insurance retention levels. The Company’s self-insurance retention levels have fluctuated over the last 10 years . As of December 31, 2021, the largest self-insured retention level for new occurrences currently maintained by the Company is $ 3.0 million per occurrence and applies to product liability claims for cranes manufactured in the United States. Product liability reserves are recorded as current liabilities in the Consolidated Balance Sheets as of December 31, 2021 and 2020 and were $ 9.0 million and $ 9.2 million, respectively. These reserves were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the current reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers. As of December 31, 2021 and 2020, the Company had reserved $ 60.2 million and $ 63.2 million, respectively, for warranty claims included in product warranties and other non-current liabilities in the Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. See Note 20, “Guarantees,” for further information. It is reasonably possible that the estimates for warranty costs, product liability, asbestos-related claims and other various legal matters may change based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. The ultimate resolution of these matters, individually and in the aggregate, is not expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows. In July 2017, the Company received an Information Request from the United States Environmental Protection Agency (“U.S. EPA”) relating to the sales of cranes manufactured between January 1, 2014 and July 31, 2017 and the Company’s related participation in the Transition Program for Equipment Manufacturers (the “TPEM” program). The TPEM program allowed equipment manufacturers to delay installing engines meeting Tier 4 final emission standards in their products, subject to certain percentage allowance restrictions. The Company has provided, and continues to provide, information to the U.S. EPA and the U.S. Department of Justice (“U.S. DOJ”) on the approximately 1,420 engines included in the Company’s cranes relating to the TPEM program and other certification matters. The Company is engaged in confidential discussions with the U.S. EPA and U.S. DOJ with respect to these matters. Based on management’s current assessment of the facts underlying these matters, the Company recorded an additional charge of $ 13.9 million in the fourth quarter of 2021 in engineering, selling and administrative expenses in the Company’s Consolidated Statements of Operations. As of December 31, 2021, the total recorded estimated liability in the Company’s Consolidated Balance Sheets is $ 14.9 million. Other than the foregoing, the Company is unable to provide further meaningful quantification as to the final resolution of these matters. However, the Company calculated the statutory maximum penalties under the Clean Air Act to be approximately $ 174.0 million. The Company believes it has strong legal and factual defenses and will vigorously defend any allegations of noncompliance and the factors that could apply in the assessment of any civil penalty. Final resolution of these matters may have a material impact on the Company’s financial condition, results of operations or cash flows. Due to the cyb ersecurity incident in June 2021, the Company experienced delays and disruptions to its business. The Company has since restored full operation of its information technology systems. The Company has insurance for this matter with a self-insured retention of $ 100,000 . Costs incurred related to the matter were immaterial to the Company's Consolidated Statement of Operations.

Guarantees

Guarantees	12 Months Ended
	Dec. 31, 2021
Guarantees [Abstract]
Guarantees	20. Guarantees The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred and the agreement is accounted for as a lease in accordance with Topic 842. If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the product is transferred to the customer. The revenue deferred related to buyback obligations accounted for under Topic 842 included in other current and non-current liabilities as of December 31, 2021 and 2020 was $ 31.0 million and $ 35.9 million, respectively. The total amount of buyback commitments given by the Company and outstanding as of December 31, 2021 and 2020 was $ 36.4 mi llion and $ 31.7 million, respectively. These amounts are not reduced for amounts the Company would recover from the repossessing and subsequent resale of the units. The buyback commitments expire at various times through 2031. The Company also has various loss guarantees with m aximum liabilities of $ 15.8 million and $ 31.8 million as of December 31, 2021 and 2020, respectively. These amounts are not reduced for amounts the Company would recover from the repossession and subsequent resale of the cranes securing the related guarantees. In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranties generally provides that products will be free from defects for periods ranging from 12 months to 60 months . If a product fails to comply with the Company’s warranty, the Company may be obligated, at its expense, to correct any defect by repairing or replacing such defective product. The Company provides for an estimate of costs that may be incurred under its standard warranty period at the time product revenue is recognized. These costs primarily include labor and materials, as necessary, associated with repair or replacement. The primary factors that affect the Company’s warranty liability include the number of units shipped and historical and anticipated warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liability and adjusts the amounts as necessary. The revenue deferred related to extended warranty periods included in other current and non-current liabilities as of December 31, 2021 and 2020 was $ 7.0 million and $ 6.2 million, respectively. Below is a table summarizing the warranty activity for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Balance at beginning of period $ 63.2 $ 60.6 $ 47.8 Accruals for warranties issued during the 30.4 33.9 47.3 Settlements made (in cash or in kind) during ( 31.3 ) ( 33.6 ) ( 34.2 ) Currency translation ( 2.1 ) 2.3 ( 0.3 ) Balance at end of period $ 60.2 $ 63.2 $ 60.6 Included in the balance at end of period as of December 31, 2021 and 2020 is $ 11.2 million and $ 13.0 million , respectively, of long-term warranty which is recorded in other non-current liabilities in the Consolidated Balance Sheets.

Restructuring

Restructuring	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring	21. Restructuring During the years ended December 31, 2021, 2020 and 2019, the Company incurred restructuring (income) expense of $( 1.1 ) million, $ 7.0 million and $ 9.8 million, respectively. Restructuring income for 2021 primarily related to adjustments of previously recorded costs associated with a lease write-off in the Americas and headcount reductions in Europe. In addition, the Company recorded income on the sale of previously expensed Brazilian tax credits. Expenses for 2020 related primarily to costs associated with headcount reductions in Europe and North America, partially offset by $ 2.5 million of income primarily related to the forfeiture of equity compensation awards associated with employee separation agreements. The costs for 2019 related primarily to severance costs for headcount reductions in Europe, North America and India. Restructuring expense for the years ended December 31, 2021, 2020 and 2019 included zero , $ 2.2 million, and zero , respectively, of expense related to executive severance. The following is a summary of the Company's restructuring activities for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Balance at beginning of period $ 5.3 $ 2.0 $ 3.3 Restructuring (income) expense* ( 1.1 ) 9.5 9.8 Use of reserve ( 2.7 ) ( 6.2 ) ( 10.9 ) Reserve reclassification — — ( 0.2 ) Currency translation 0.1 — — Balance at end of period $ 1.6 $ 5.3 $ 2.0 *Restructuring expense within the rollforward excludes income related to the forfeiture of equity compensation awards associated with employee separation agreements which was recorded directly to restructuring expense in the Consolidated Statement of Operations and, therefore, did not impact the restructuring accrual.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Employee Benefit Plans	22. Employee Benefit Plans The Company provides defined benefit pension plans, defined contribution plans and/or other postretirement benefit plans to employees in many of the Company’s locations throughout the world. The Company’s defined benefit plans provide a benefit based on years of service and/or the employee’s average earnings near retirement. The Company’s defined contribution plans allow employees to contribute a portion of their salary to help save for retirement, and in most cases, the Company provides a matching contribution. The benefit obligation related to the Company’s non-U.S. defined benefit pension plans are for employees located primarily in Europe. For postretirement medical and other benefit plans, all of the Company’s benefit obligation is for employees located in the United States. Defined contribution plans The Company maintains two defined contribution retirement plans for its employees in the United States: (1) The Manitowoc Company, Inc. 401(k) Retirement Plan (the “Manitowoc 401(k) Retirement Plan”) and (2) The Manitowoc Company, Inc. Deferred Compensation Plan (the “Manitowoc Deferred Compensation Plan”). During 2019, the Manitowoc Retirement Savings Plan merged with The Manitowoc 401(k) Retirement Plan, with The Manitowoc 401(k) Retirement Plan being the surviving plan. Each plan results in individual participant balances that reflect a combination of amounts contributed by the Company or deferred by the participant, amounts invested at the direction of either the Company or the participant, and the continuing reinvestment of returns until the accounts are distributed. The Company also has various other non-U.S. defined contribution plans that allow eligible employees to contribute a portion of their salary to the plans. In most cases, the Company provides a matching contribution to the funds. Company contributions to the plans are generally based upon formulas contained in the plans. Total costs incurred under the Non-U.S. defined contribution plans, and reported within the Consolidated Statement of Operations, were $ 1.6 million , $ 1.7 million and $ 1.2 million for the years ended December 31, 2021, 2020 and 2019, respectively. Manitowoc 401(k) Retirement Plan The Manitowoc 401(k) Retirement Plan is a tax-qualified retirement plan that is available to substantially all U.S. employees of Manitowoc, its subsidiaries and related entities. The Manitowoc 401(k) Retirement Plan allows employees to make both pre and after-tax elective deferrals, subject to certain limitations under the Internal Revenue Code of 1986, as amended (the “Tax Code”). The Company also has the right to make the following additional contributions: (1) a safe harbor matching contribution and (2) an additional contribution, which may or may not be made, at the full discretion of the Company and for which the value will be fully determined by the Company based on its performance. Each participant in the Manitowoc 401(k) Retirement Plan is allowed to direct the investment of that participant’s account among a diverse mix of investment funds, including a Company stock alternative. To the extent that any funds are invested in the Company’s stock, that portion of the Manitowoc 401(k) Retirement Plan is an employee stock ownership plan, as defined under the Tax Code (an “ESOP”). The terms governing the retirement benefits under the Manitowoc 401(k) Retirement Plan are the same for the Company’s executive officers as they are for other eligible employees in the U.S. Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, were $ 5.8 million, $ 5.9 million and $ 6.3 million for the years ended December 31, 2021, 2020 and 2019, respectively. Manitowoc Deferred Compensation Plan The Manitowoc Deferred Compensation Plan is a non-qualified supplemental deferred compensation plan for highly compensated and key management employees and for non-employee directors of the Company. The Company maintains the Manitowoc Deferred Compensation Plan to allow eligible individuals to save for retirement in a tax-efficient manner despite Tax Code restrictions that would otherwise impair their ability to do so under the Manitowoc 401(k) Retirement Plan. The Manitowoc Deferred Compensation Plan also assists the Company in retaining those key employees and directors. The Manitowoc Deferred Compensation Plan accounts are credited with: (1) elective deferrals made at the request of the individual participant; and/or (2) an additional contribution from the Company for each individual participant, which may or may not be made, at the full discretion of the Company based on its performance. Although unfunded within the meaning of the Tax Code, the Manitowoc Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s corresponding future benefit obligations. Each participant in the Manitowoc Deferred Compensation Plan is credited with earnings based upon individual elections from a diverse mix of investment funds that are intended to reflect investment funds similar to those offered under the Manitowoc 401(k) Retirement Plan, including the Company’s stock. Participants do not receive preferential or above-market rates of return under the Manitowoc Deferred Compensation Plan. The Company has two separate investment programs: Program A and B, which allows participants to direct deferrals and Company contributions and restricts the Company’s use and access to the funds, but are subject to the claims of the Company’s general creditors in rabbi trusts. Program A invests solely in the Company’s stock; dividends paid on the Company’s stock are automatically reinvested; and all distributions must be made in Company stock. Program B offers a variety of investment options but does not include Company stock as an investment option. All distributions from Program B must be made in cash. Participants cannot transfer assets between programs. Program A is accounted for as a plan that does not permit diversification. As a result, the Company stock held by Program A is classified in equity in a manner similar to accounting for treasury stock. The deferred compensation obligation is classified as an equity instrument. Changes in the fair value of the Company’s stock and the compensation obligation are not recognized. The asset and obligation for Program A were $ 0.2 million and $ 0.6 million as of December 31, 2021 and 2020, respectively. Program B is accounted for as a plan that permits diversification. As a result, the assets held by Program B are classified as an asset in the Consolidated Balance Sheets and changes in the fair value of the assets are recognized in earnings. The deferred compensation obligation is classified as a liability in the Consolidated Balance Sheets and adjusted, with a charge or credit to compensation cost, to reflect changes in the fair value of the obligation. The assets, which are included in other non-current assets, and obligations, which are included in other non-current liabilities, were $ 8.9 million and $ 9.0 million as of December 31, 2021 and 2020, respectively. Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, for the years ended December 31, 2021, 2020 and 2019 were $ 0.1 million, $ 0.4 million and $ 0.5 million, respectively. Pension, Postretirement Medical and Other Benefit Plans The Company provides certain pension, postretirement medical and other benefits (death benefits) for eligible retirees and their dependents. Certain pension benefits are funded, the postretirement medical benefits are not funded but are paid as incurred, and the death benefits are fully insured. Eligibility for coverage is based on meeting certain years of service and retirement qualifications. The healthcare benefits may be subject to deductibles, co-payment provisions, and other limitations. The Company has reserved the right to modify these benefits which have been frozen. As of December 31, 2010, all of the remaining U.S. defined benefit pension plans were merged into a single plan: the Manitowoc U.S. Pension Plan (“U.S. Pension Plans”). All merged plans had benefit accruals frozen prior to the merger of the plans. In addition to the U.S. Pension Plans, the Company also maintains defined benefit pension plans for various Non-US subsidiaries which are sponsored directly by the Company or its subsidiaries and offered only to employees or retirees of those subsidiaries (“Non-U.S. Pension Plans”). Certain Non-U.S. Pension Plans have frozen benefit accruals. During 2021, the unvested portion of Portugal's pension plan was transferred to a defined contribution plan. As a result, the Company recognized a settlement gain of $ 0.9 million. The components of periodic benefit costs for the years ended December 31, 2021, 2020 and 2019 are as follows: US Pension Plans Non-US Pension Plans Postretirement Medical 2021 2020 2019 2021 2020 2019 2021 2020 2019 Service cost - benefits earned $ — $ — $ — $ 2.3 $ 2.1 $ 1.8 $ 0.1 $ 0.2 $ 0.2 Interest cost of projected 2.8 4.0 5.1 1.5 1.8 2.2 0.2 0.4 0.8 Expected return on assets ( 4.9 ) ( 5.2 ) ( 4.3 ) ( 1.0 ) ( 1.1 ) ( 1.4 ) — — — Amortization of prior service — — — 0.1 0.1 0.1 ( 2.7 ) ( 2.7 ) ( 2.8 ) Amortization of actuarial net 3.2 2.8 3.3 1.8 1.7 1.3 ( 0.3 ) — — Pension settlement charge — — — ( 0.9 ) — — — — — Net periodic benefit cost $ 1.1 $ 1.6 $ 4.1 $ 3.8 $ 4.6 $ 4.0 $ ( 2.7 ) $ ( 2.1 ) $ ( 1.8 ) Weighted average Effective discount rate for 2.4 % 3.3 % 4.3 % 1.2 % 1.6 % 2.5 % 2.0 % 2.9 % 4.1 % Effective interest rate on 2.0 % 2.9 % 4.0 % 1.2 % 1.6 % 2.5 % 1.3 % 2.6 % 3.7 % Expected return on 4.3 % 5.2 % 5.2 % 1.6 % 2.3 % 3.5 % N/A N/A N/A Rate of compensation N/A N/A N/A 4.1 % 3.1 % 3.6 % N/A N/A N/A The prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10 % of the greater of the benefit obligation and the market-related value of assets are amortized over the average remaining service period of active participants. To develop the expected long-term rate of return on assets assumptions, the Company considered the historical returns and future expectations for returns in each asset class net of fees, as well as targeted asset allocation percentages within the pension portfolio. The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2021 and 2020: US Pension Plans Non-US Pension Plans Postretirement 2021 2020 2021 2020 2021 2020 Change in Benefit Obligation Benefit obligation, beginning of year $ 151.9 $ 142.3 $ 104.9 $ 90.6 $ 15.8 $ 18.4 Service cost — — 2.3 2.1 0.1 0.2 Interest cost 2.8 4.0 1.5 1.8 0.2 0.4 Participant contributions — — — — 0.3 0.3 Plan curtailment — — ( 0.3 ) ( 0.1 ) — — Actuarial (gain) loss ( 5.4 ) 13.4 ( 3.7 ) 9.7 ( 1.0 ) ( 1.3 ) Currency translation adjustment — — ( 4.2 ) 5.3 — — Pension settlement — — ( 1.9 ) — — — Benefits paid ( 8.1 ) ( 7.8 ) ( 4.1 ) ( 4.5 ) ( 1.7 ) ( 2.2 ) Benefit obligation, end of year $ 141.2 $ 151.9 $ 94.5 $ 104.9 $ 13.7 $ 15.8 Change in Plan Assets Fair value of plan assets, beginning of year $ 113.7 $ 99.6 $ 52.3 $ 45.2 $ — $ — Actual return on plan assets 8.5 12.7 0.6 6.0 — — Employer contributions 0.5 9.2 3.9 3.9 1.4 1.9 Participant contributions — — — — 0.3 0.3 Currency translation adjustment — — ( 0.6 ) 1.7 — — Pension settlement — — ( 1.9 ) — — — Benefits paid ( 8.1 ) ( 7.8 ) ( 4.1 ) ( 4.5 ) ( 1.7 ) ( 2.2 ) Fair value of plan assets, end of year 114.6 113.7 50.2 52.3 — — Funded status $ ( 26.6 ) $ ( 38.2 ) $ ( 44.3 ) $ ( 52.6 ) $ ( 13.7 ) $ ( 15.8 ) Amounts recognized in the Consolidated Short-term pension obligation $ ( 0.5 ) $ ( 0.5 ) $ ( 1.0 ) $ ( 1.1 ) $ — $ — Long-term pension obligation ( 26.1 ) ( 37.7 ) ( 43.3 ) ( 51.5 ) — — Short-term postretirement medical and other — — — — ( 1.6 ) ( 1.8 ) Long-term postretirement medical and other — — — — ( 12.1 ) ( 14.0 ) Net amount recognized $ ( 26.6 ) $ ( 38.2 ) $ ( 44.3 ) $ ( 52.6 ) $ ( 13.7 ) $ ( 15.8 ) Weighted-Average Assumptions Discount rate 2.8 % 2.4 % 1.4 % 1.1 % 2.5 % 2.0 % Expected return on plan assets 4.3 % 5.2 % 1.6 % 2.3 % N/A N/A Rate of compensation increase N/A N/A 4.1 % 3.1 % N/A N/A The Company prepares its discount rates with advice from an independent third party. The Company uses different discount rates for each plan depending on the plan jurisdiction, the demographics of participants and the expected timing of benefit payments. For the qualified U.S. pension plan and postretirement medical plans, the Company uses a discount rate calculated based on an appropriate mix of high-quality corporate bonds. For the non-U.S. pension and postretirement plans, the Company consistently uses the relevant country specific benchmark indices for determining the various discount rates. Amounts recognized in accumulated other comprehensive loss as of December 31, 2021 and 2020, are summarized as follows: Pensions Postretirement 2021 2020 2021 2020 Net actuarial gain (loss) $ ( 51.3 ) $ ( 69.3 ) $ 4.0 $ 3.3 Prior service credit (cost) ( 0.4 ) ( 0.4 ) 1.4 4.1 Total amount recognized $ ( 51.7 ) $ ( 69.7 ) $ 5.4 $ 7.4 For measurement purposes, a 5.24 % annual rate of increase in the per capita cost of covered health care benefits was assumed for the postretirement medical and other plan for 2021. The rate was assumed to decrease gradually to 4.50 % in 2038 and remain at that level thereafter. Assumed health care cost trend rates have a significant effect on the amounts reported for the postretirement medical and other plan. The following table summarizes the sensitivity of our December 31, 2021 retirement obligations and 2022 retirement benefit costs of our plans to changes in the key assumptions used to determine those results: Change in assumption: Estimated Estimated Estimated increase Estimated 0.50% increase in discount rate $ ( 1.0 ) $ ( 14.2 ) N/A $ ( 0.4 ) 0.50% decrease in discount rate 1.1 15.8 N/A 0.4 0.50% increase in long-term return on assets ( 0.8 ) N/A N/A N/A 0.50% decrease in long-term return on assets 0.8 N/A N/A N/A 1.0% increase in medical trend rates N/A N/A 0.1 0.4 1.0% decrease in medical trend rates N/A N/A ( 0.1 ) ( 0.4 ) It is reasonably possible that the estimate for future retirement and medical costs may change in the near future due to changes in interest rates. Presently, there is no reliable means to estimate the amount of any such potential changes. The weighted-average asset allocations of the U.S. pension plans as of December 31, 2021 and 2020, by asset category are as follows: 2021 2020 Equity 52.7 % 53.3 % Fixed income 38.2 % 38.8 % Other 9.1 % 7.9 % Total 100.0 % 100.0 % The weighted-average asset allocations of the Non-U.S. pension plans as of December 31, 2021 and 2020, by asset category are as follows: 2021 2020 Equity 0.0 % 0.0 % Fixed income 41.3 % 45.6 % Other* 58.7 % 54.4 % Total 100.0 % 100.0 % *Includes diversified investments that have equity and The Board of Directors has established the Retirement Plan Committee (the “Committee”) to manage the operations and administration of all benefit plans and related trusts. On a quarterly basis, the Committee reviews progress toward achieving the pension plans’ and individual investment managers’ performance objectives. Investment Strategy The overall objective of the Company's pension assets is to earn a rate of return over time to satisfy the benefit obligations of the pension plans and to maintain sufficient liquidity to pay benefits and address other cash requirements of the pension funds. Specific investment objectives for the Company’s long-term investment strategy include reducing the volatility of pension assets relative to pension liabilities, achieving a competitive, total investment return, achieving diversification between and within asset classes and managing other risks. Investment objectives for each asset class are determined based on specific risks and investment opportunities identified. The Company reviews its long-term, strategic asset allocations annually. The Company uses various analytics to determine the optimal asset mix and considers plan liability characteristics, liquidity characteristics, funding requirements, expected rates of return and the distribution of returns. The Company identifies investment benchmarks for the asset classes in the strategic asset allocation that are market-based. Actual allocations to each asset class vary from target allocations due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced monthly. The actual and target allocations for the pension assets as of December 31, 2021, by asset class, are as follows: Target Allocations Weighted Average Asset U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Equity Securities 50 % 0 % 52.7 % 0.0 % Debt Securities 40 % 40 % 38.2 % 41.3 % Other 10 % 60 % 9.1 % 58.7 % Risk Management In managing the plan assets, the Company reviews and manages risk associated with funded status risk, interest rate risk, market risk, counterparty risk, liquidity risk and operational risk. Liability management and asset class diversification are central to the Company’s risk management approach and are integral to the overall investment strategy. Further, asset classes are constructed to achieve diversification by investment strategy, by industry or sector and by holding. Asset performance is monitored against benchmarked indices. Fair Value Measurements The following table presents the Company’s plan assets using the fair value hierarchy as of December 31, 2021 and 2020. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. See Note 5, “Fair Value of Financial Instruments,” for definitions of each fair value level. December 31, 2021 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 32.7 $ 32.7 International equity — — — 31.9 31.9 Fixed income: Corporate bonds and notes — — — 27.1 27.1 Government and agency bonds — — — 34.7 34.7 Commingled funds — — — 18.9 18.9 International fixed income — — — 2.2 2.2 Other: Cash and cash equivalents 0.7 — — — 0.7 Money market funds — 0.7 — — 0.7 Annuity contracts — — 12.6 — 12.6 Other — — — 3.3 3.3 Total $ 0.7 $ 0.7 $ 12.6 $ 150.8 $ 164.8 * Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. December 31, 2020 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 32.3 $ 32.3 International equity — — — 30.6 30.6 Fixed income: Corporate bonds and notes — — — 35.7 35.7 Government and agency bonds — — — 30.1 30.1 Commingled funds — — — 17.8 17.8 International fixed income — — — 0.5 0.5 Other: Cash and cash equivalents 0.6 — — — 0.6 Money market funds — 0.7 — — 0.7 Annuity contracts — — 12.9 — 12.9 Other — — — 4.8 4.8 Total $ 0.6 $ 0.7 $ 12.9 $ 151.8 $ 166.0 *Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Cash and cash equivalents, which are used to pay benefits, are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments. Insurance group annuity contracts are valued at the present value of the future benefit payments owed by the insurance Company to the Non-U.S. Pension Plans’ participants. The valuation methodologies described above may generate a fair value calculation that may not be indicative of net realizable value or future fair values. While the Company believes the valuation methodologies used are appropriate, the use of different methodologies or assumptions in calculating fair value could result in different amounts. A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows: Insurance Contracts 2021 2020 Beginning Balance $ 12.9 $ 12.6 Actual return on assets 0.7 0.9 Benefit payments ( 0.9 ) ( 1.0 ) Foreign currency impact ( 0.1 ) 0.4 Ending Balance $ 12.6 $ 12.9 The expected 2022 minimum contributions for the U.S. pension plans are $ 0.9 million and there are no planned discretionary or non-cash contributions. The expected 2022 minimum contributions for the non-U.S. pension plans are $ 3.0 million and there are no planned discretionary or non-cash contributions. Expected Company paid claims for the postretirement medical and other plans are $ 1.6 million for 2022 . Projected future benefit payments from the plans as of December 31, 2021 are estimated as follows: U.S Pension Non-U.S. Postretirement 2022 $ 8.7 $ 2.8 $ 1.6 2023 8.7 3.0 1.5 2024 8.8 3.2 1.4 2025 8.8 3.7 1.3 2026 8.7 3.9 1.2 Thereafter 41.7 22.8 4.6 Total $ 85.4 $ 39.4 $ 11.6 The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2021 and 2020 is as follows: U.S Pension Plans Non U.S. Pension Plans 2021 2020 2021 2020 Projected benefit obligation $ 141.2 $ 151.9 $ 93.5 $ 104.9 Accumulated benefit obligation 141.2 151.9 89.1 99.3 Fair value of plan assets 114.6 113.7 50.2 52.3 The measurement date for all plans is December 31, 2021 .

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	23. Leases The Company has operating leases for offices, warehouses, land for storage of cranes, vehicles, information technology equipment and manufacturing equipment. The remaining lease terms are up to 22 years, some of which include options to extend the lease term for up to 10 years, and some which include options to terminate the lease within one year . Certain leases include one or more options to renew; the exercise of lease renewal options is at the Company’s discretion. The Company includes renewal option periods in the lease term when it is determined that the options are reasonably certain to be exercised. The Company’s financing leases have an immaterial impact on the consolidated financial statements. The components of lease expense for the years ended December 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Operating lease cost $ 13.2 $ 13.2 $ 14.4 Variable lease cost* 1.5 1.5 1.4 Total lease cost $ 14.7 $ 14.7 $ 15.8 *Includes short-term leases, which are immaterial. Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Operating lease right-of-use assets $ 40.6 $ 37.9 Other liabilities $ 12.3 $ 10.5 Operating lease liabilities 29.2 28.4 Total operating lease liabilities $ 41.5 $ 38.9 Cash paid for operating leases included in operating cash flows was $ 25.1 million, $ 24.5 million and $ 27.4 million for the years ended December 31, 2021, 2020 and 2019 respectively. As of December 31, 2021, the Company’s operating leases have a weighted-average remaining lease term of 6.3 years and a weighted average discount rate of 3.8 %. As of December 31, 2020 , the Company's leases had a weighted-average remaining lease term of 6.5 years and a weighted average discount rate of 3.81 %. Topic 842 requires a lessee to discount its unpaid lease obligations using the interest rate implicit in the lease, or if not readily determinable, the incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the implicit rate cannot be determined. The Company’s incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms in a similar region. Maturities of operating lease liabilities as of December 31, 2021 are summarized as follows: Year 2022 $ 12.2 2023 9.3 2024 6.6 2025 4.2 2026 3.2 Thereafter 8.8 Total lease payments 44.3 Less: imputed interest ( 2.8 ) Present value of lease liabilities $ 41.5 Lessor Accounting The Company rents cranes to its customers and actively manages the size, quality, age and composition of the rental fleet to meet customer demands and trends. The rental fleet is serviced through the Company’s on-site parts and service team. The rental activities create cross-selling opportunities in crane sales including rent-to-own purchase options whereby customers are given a period of time to exercise an option to purchase the related equipment at an established price with any rental payments paid applied to reduce the purchase price. All of the Company's leasing arrangements are classified as operating leases. Rental revenue is recognized on a straight-line basis over the rental period. In most cases, the Company's rental arrangements include non-lease components, including delivery and pick-up services. The Company accounts for these non-lease components separate from the rental arrangement and recognizes the revenue associated with these components when the service is performed. The Company has elected to exclude from rental revenue all taxes collected from customers related to rental activities. The Company manages the residual value risk of its rented assets by (i) monitoring the quality, aging and anticipated retail market value of the rental fleet assets to determine the optimal period to remove an asset from the rental fleet, (ii) maintaining the quality of assets through on-site parts and service support and (iii) requiring physical damage insurance of customers. The Company primarily disposes of the rental assets through its rent to own program or sale of the asset. Refer to Note 9, “Property, Plant and Equipment" for the balance of rental cranes included in property, plant and equipment in the Consolidated Balance Sheets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents.
Inventories	any specific customer collection issues the Company has identified. The following table is a rollforward of the allowance for doubtful accounts for the years ended December 31, 2021 and 2020. 2021 2020 Balance at beginning of period $ 8.5 $ 7.9 Bad debt expenses — 3.6 Use of reserve ( 1.3 ) ( 2.7 ) Currency translation 0.1 ( 0.3 ) Balance at end of period $ 7.3 $ 8.5 Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out method.
Business Combinations	Business Combinations The Company accounts for business combinations under the acquisition method in accordance with Accounting Standards Codification ("ASC") Topic 805, Business Combinations ("Topic 805"). The acquisition method requires identifiable assets acquired and liabilities assumed and any non-controlling interest in the business acquired be recognized and measured at fair value on the acquisition date, which is the date that the Company obtains control of the acquired business. The amount by which the fair value of consideration transferred as the purchase price exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The Company expenses transaction costs in a business combination.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The Company accounts for goodwill and other intangible assets under the guidance of ASC Topic 350-10, “Intangibles — Goodwill and Other” ("Topic 350"). Under ASC Topic 350, goodwill is not amortized; instead, the Company performs an annual impairment review. The date for the annual impairment review is October 31, 2021 or more frequently if events or changes in circumstances indicate that the assets might be impaired. To perform its goodwill impairment review, the Company uses the income approach and market approach with a weighting of 70/30, respectively, to fair value each reporting unit. If the carrying amount exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of the goodwill. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value. The Company’s other intangible assets with indefinite lives, are not amortized but are tested for impairment annually, or more frequently, as events dictate. For other indefinite lived intangible assets, the impairment test consists of a comparison of the fair value of the intangible assets to their carrying amount. See Note 10, “Goodwill and Other Intangible Assets,” for further details on our impairment assessments. The Company’s intangible assets subject to amortization are tested for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable. The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives: Useful lives Patents 20 years Customer relationships 12 - 18 years Trademarks and tradenames 5 years Noncompetition agreements 5 years Other intangibles 9 months
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance, repairs and minor renewals are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and depreciated over the remaining estimated useful life. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the asset’s estimated useful life using the straight-line depreciation method for financial reporting and accelerated methods for income tax purposes. Property, plant and equipment are depreciated over the following estimated useful lives: Years Building and improvements 2 - 43 Machinery, equipment and tooling 3 - 18 Furniture and fixtures 3 - 10 Computer hardware and software 3 - 10 Rental cranes 5 - 15 Property, plant and equipment also includes cranes accounted for as operating leases. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer at the time of the order had a significant economic incentive to exercise. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of buyback and rental equipment included in property, plant and equipment amounted to $ 119.5 million and $ 59.9 million, net of accumulated depreciation, as of December 31, 2021 and 2020, respectively. The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If an impairment is determined to exist, any related impairment loss is calculated based upon comparison of the expected undiscounted future cash flows to the net book value of the assets.
Warranties	Warranties Estimated manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs during the extended warranty period are expensed as incurred.
Product Liabilities	Product Liabilities The Company records product liability reserves for its self-insured portion of any outstanding product liability cases when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates.
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC Topic 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge. The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates. The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes expense net of estimated future forfeitures for all stock-based compensation on a straight-line basis over the vesting period of the entire award. Estimated future forfeitures are based on the Company’s historical experience. Stock-based compensation plans are described more fully in Note 17, “Stock-Based Compensation.”
Research and Development	Research and Development Research and development costs are charged to expense as incurred and amounted to $ 29.1 million, $ 30.6 million and $ 31.1 million for the years ended December 31, 2021, 2020 and 2019 , respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs.
Income Taxes	Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority.
Net Income (Loss) Per Share	Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted net income (loss) per share reflects the effect of all potential dilutive shares that were outstanding during the respective periods, unless the effect of doing so would be antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net income (loss) , other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments.
Net Sales	Net Sales Sales are recognized when obligations under the terms of a contract with the Company’s customer are satisfied; generally this occurs with the transfer of control of the Company’s cranes or aftermarket parts or completion of performance of services. Sales are measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. The Company recognizes sales for extended warranties over the life of the extended warranty period. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from sales. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are categorized as a fulfillment cost and are included in cost of sales on the Consolidated Statement of Operations. Performance Obligations The following is a description of principle activities from which the Company generates sales. Disaggregation of the Company’s revenue sources are disclosed in Note 18, “Segments.” Crane Sales Crane sales are primarily generated through the sale of new and used cranes. Contracts with customers are generally in the form of a purchase order. Based on the nature of the Company’s contracts, the Company does not have any significant financing terms. Contracts may have variable consideration in the form of early pay discounts or rebates, however variable consideration is not material to the overall contract with the customer. Sales are earned under these contracts when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier or acceptance through an independent inspection company that acts as an agent of the customer. From time to time, the Company enters into agreements where the customer has the right to exercise a put option requiring the Company to buyback a crane at an agreed upon price. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise that right. If it is determined that the customer has a significant economic incentive to exercise that right, the agreement is accounted for as a lease in accordance with ASC Topic 842 “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the asset is transferred to the customer. Refer to Note 20, “Guarantees” for additional information. Given the nature of the Company’s products, the customer may request that the product be held until a delivery location is identified. Under these “bill and hold” arrangements, sales are recognized when all of the following criteria are met: 1) the reason for the bill-and-hold arrangement is substantive, 2) the product is separately identified as belonging to the customer, 3) the product is ready for transfer to the customer, and 4) the Company does not have the ability to use the product or direct it to another customer. Aftermarket Part Sales Aftermarket part sales are generated through the sale of new and used parts to end customers and distributors. Aftermarket part sales are recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Customers generally have a right of return which the Company estimates using historical information. The amount of estimated returns is deducted from net sales. Other Sales The Company’s other sales consist primarily of sales from: • Repair and field service work; • Rental of cranes; and • Training and technical publications. The Company’s performance obligations for other sales generally relates to performing specific agreed upon services. Sales are earned upon the completion of those services. Practical Expedients and Exemptions The Company expenses sales commissions when incurred because the amortization period would be one year or less. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations. The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.
Recent Accounting Changes and Pronouncements	Recent Accounting Changes and Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 “Income Taxes (Topic 740).” The amendments in this ASU simplify accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The standard is effective for annual periods beginning after December 15, 2020. The adoption of ASU 2019-02 did not have a material impact on the Company’s consolidated financial statements.
Fair Value Measurement	ASC Topic 820-10 ("ASC 820") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or Inputs other than quoted prices that are observable for the asset or liability Level 3 Unobservable inputs for the asset or liability

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of Rollforward of the Allowance for Doubtful Accounts	The following table is a rollforward of the allowance for doubtful accounts for the years ended December 31, 2021 and 2020. 2021 2020 Balance at beginning of period $ 8.5 $ 7.9 Bad debt expenses — 3.6 Use of reserve ( 1.3 ) ( 2.7 ) Currency translation 0.1 ( 0.3 ) Balance at end of period $ 7.3 $ 8.5
Schedule of Estimated Useful Lives of Other Intangible Assets Subject to Amortization	The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives: Useful lives Patents 20 years Customer relationships 12 - 18 years Trademarks and tradenames 5 years Noncompetition agreements 5 years Other intangibles 9 months
Schedule of Estimated Useful Lives of Property, Plant and Equipment	Property, plant and equipment are depreciated over the following estimated useful lives: Years Building and improvements 2 - 43 Machinery, equipment and tooling 3 - 18 Furniture and fixtures 3 - 10 Computer hardware and software 3 - 10 Rental cranes 5 - 15

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Schedule of assets acquired and liabilities based upon their estimated fair value	The purchase price was allocated to underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of the combination as follows: Net working capital $ 50.0 Property, plant and equipment 13.1 Rental fleet 48.2 Goodwill 8.9 Noncompetition agreement intangible 3.8 Customer relationships intangible 15.1 Total fair value consideration $ 139.1

Net Sales (Tables)

Net Sales (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Schedule of Change In Customer Advances Balance	The table below shows the change in the customer advances balance for the year ended December 31, 2021 and 2020. 2021 2020 Balance at beginning of period $ 25.5 $ 25.8 Cash received in advance of satisfying 128.4 108.0 Revenue recognized ( 124.5 ) ( 108.5 ) Currency translation ( 0.7 ) 0.2 Balance at end of period $ 28.7 $ 25.5

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by Level within the Fair Value Hierarchy	The following tables sets forth the Company’s financial assets and liabilities related to FX Forward Contracts that were accounted for at fair value as of December 31, 2021 and 2020. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Fair Value as of December 31, 2021 Level 1 Level 2 Level 3 Total Recognized Location FX Forward Contracts $ — $ 0.3 $ — $ 0.3 Accounts payable and accrued expenses Fair Value as of December 31, 2020 Level 1 Level 2 Level 3 Total Recognized Location FX Forward Contracts $ — $ — $ — $ — Other current assets FX Forward Contracts $ — $ — $ — $ — Accounts payable and accrued expenses

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Foreign Currency Exchange Contracts
Derivative Instruments Gain Loss [Line Items]
Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts	The gains (losses) recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2021 and 2020 are summarized as follows: Recognized Location 2021 2020 2019 Designated Cost of sales $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Non-Designated Other income (expense) - net 0.4 0.6 3.9

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of the components of inventories	The components of inventories as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Raw materials $ 157.4 $ 89.6 Work-in-process 140.4 102.3 Finished goods 279.0 281.2 Total Inventories — net $ 576.8 $ 473.1

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	The components of property, plant and equipment as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Land $ 19.4 $ 20.3 Building and improvements 203.4 203.7 Machinery, equipment and tooling 298.9 292.6 Furniture and fixtures 14.5 21.0 Computer hardware and software 125.6 119.3 Rental cranes 144.2 90.2 Construction in progress 15.1 9.0 Total cost 821.1 756.1 Less accumulated depreciation ( 462.3 ) ( 461.8 ) Property, plant and equipment — net $ 358.8 $ 294.3

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in goodwill by reportable segment	The changes in carrying amount of goodwill for the years ended December 31, 2021 and 2020 are as follows: Americas - Manufacturing Americas - Distribution MEAP Consolidated Balance as of January 1, 2020 $ 166.5 $ — $ 66.0 $ 232.5 Foreign currency impact — — 2.6 2.6 Net balance as of December 31, 2020 166.5 — 68.6 235.1 Foreign currency impact — — ( 0.5 ) ( 0.5 ) Acquisitions — 15.1 — 15.1 Net balance as of December 31, 2021 $ 166.5 $ 15.1 $ 68.1 $ 249.7
Gross carrying amount and accumulated amortization of the company's intangible assets other than goodwill	The gross carrying amount, accumulated amortization and net book value of the Company’s intangible assets other than goodwill as of December 31, 2021 and 2020 are summarized as follows: December 31, 2021 December 31, 2020 Gross Accumulated Net Gross Accumulated Net Definite lived intangible assets: Customer relationships $ 27.0 $ ( 9.0 ) $ 18.0 $ 9.9 $ ( 8.6 ) $ 1.3 Patents 29.7 ( 29.1 ) 0.6 31.0 ( 30.3 ) 0.7 Noncompetition agreements 4.2 ( 0.4 ) 3.8 — — — Trademarks and tradenames 2.2 ( 0.1 ) 2.1 — — — Other intangibles 0.6 ( 0.2 ) 0.4 — — — Total 63.7 ( 38.8 ) 24.9 40.9 ( 38.9 ) 2.0 Indefinite lived intangible assets: Trademarks and tradenames 95.9 — 95.9 100.0 — 100.0 Distribution network 18.8 — 18.8 19.6 — 19.6 Total 114.7 — 114.7 119.6 — 119.6 Total other intangible assets $ 178.4 $ ( 38.8 ) $ 139.6 $ 160.5 $ ( 38.9 ) $ 121.6
Estimated Amortization Expense	Excluding the impact of any future acquisitions, divestitures or impairments, the Company's anticipated future amortization of intangible assets as of December 31, 2021 is as follows: Year 2022 $ 3.3 2023 2.9 2024 2.9 2025 2.9 2026 2.7 Thereafter 10.1 Total $ 24.8

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued expenses	Accounts payable and accrued expenses as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Trade accounts payable $ 238.8 $ 178.1 Employee-related expenses 51.9 38.5 Accrued vacation 22.2 22.4 Miscellaneous accrued expenses 100.5 90.4 Total accounts payable and accrued expenses $ 413.4 $ 329.4

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of outstanding debt	Outstanding debt as of December 31, 2021 and 2020 is summarized as follows: 2021 2020 Borrowing under senior secured asset based revolving $ 100.0 $ — 2026 Notes 300.0 300.0 Other 10.3 14.7 Deferred financing costs ( 3.1 ) ( 3.8 ) Total debt 407.2 310.9 Short-term borrowings and current portion of ( 7.3 ) ( 10.5 ) Long-term debt $ 399.9 $ 300.4
Schedule of revolving credit facility bear interest at variable rate based upon average quarterly availability	The variable interest rate is based upon the average availability as of the most recent determination date as follows: Average quarterly availability Alternative base rate spread Eurodollar and overnight LIBOR spread ≥ 50% of Aggregate Commitment 0.25 % 1.25 % < 50% of Aggregate Commitment 0.50 % 1.50 %
Schedule of aggregate future maturities of outstanding debt obligations	The aggregate scheduled future maturities of outstanding debt obligations as of December 31, 2021 is as follows: Year 2022 $ 7.3 2023 1.4 2024 101.5 2025 0.1 2026 300.0 Thereafter — Total $ 410.3

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Summary of Income (Loss) from Continuing Operations Before Income Taxes	Income (loss) before income taxes for the years ended December 31, 2021, 2020 and 2019 is summarized as follows: 2021 2020 2019 Income (loss) before income taxes: U.S. $ ( 39.0 ) $ ( 51.6 ) $ ( 10.0 ) Non-U.S. 56.1 49.6 69.0 Total $ 17.1 $ ( 2.0 ) $ 59.0
Schedule of Income Tax Expense (Benefit)	Income tax provision (benefit) for the years ended December 31, 2021, 2020 and 2019 is summarized as follows: 2021 2020 2019 Current: U.S. federal and state $ ( 1.2 ) $ ( 4.3 ) $ ( 0.7 ) Non-U.S. 7.9 16.6 11.6 Total current $ 6.7 $ 12.3 $ 10.9 Deferred: U.S. federal and state $ 0.6 $ 0.3 $ 0.2 Non-U.S. ( 1.2 ) 4.5 1.3 Total deferred $ ( 0.6 ) $ 4.8 $ 1.5 Income tax provision $ 6.1 $ 17.1 $ 12.4
Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations	The calculated U.S. federal income tax amount at the statutory rate of 21 % is reconciled to the Company’s income tax provision (benefit) for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 U.S. federal income tax at statutory rate $ 3.6 $ ( 0.4 ) $ 12.4 U.S. state income tax provision 0.3 1.9 ( 0.1 ) Manufacturing and research incentives ( 0.2 ) ( 0.8 ) ( 3.0 ) Taxes on non-U.S. income which differ from the U.S. 1.5 — ( 2.6 ) Adjustments for unrecognized tax benefits ( 2.3 ) 10.7 ( 1.3 ) Adjustments for valuation allowances 4.5 22.2 4.5 U.S. tax reform ( 1.6 ) ( 14.6 ) 4.0 Other items 0.3 ( 1.9 ) ( 1.5 ) Income tax provision $ 6.1 $ 17.1 $ 12.4
Schedules of Deferred Tax Assets (Liabilities)	Temporary differences and carryforwards that give rise to deferred tax assets and liabilities include the following items: 2021 2020 Deferred income tax assets: Inventories $ 23.9 $ 22.8 Deferred employee benefits 30.8 34.7 Product warranty reserves 8.9 9.3 Product liability reserves 2.0 2.0 Tax credits 7.4 7.7 Loss and other tax attribute carryforwards 151.1 142.6 Deferred revenue 2.4 3.9 Other 20.6 18.0 Total deferred income tax assets 247.1 241.0 Less valuation allowance ( 170.5 ) ( 171.4 ) Net deferred income tax assets $ 76.6 $ 69.6 Deferred income tax liabilities Accounts receivable 1.5 2.7 Property, plant and equipment 23.0 17.2 Intangible assets 34.7 36.0 Total deferred income tax liabilities $ 59.2 $ 55.9 Net deferred income tax assets $ 17.4 $ 13.7 The net deferred tax assets reflected in the Consolidated Balance Sheets for the years ended December 31, 2021 and 2020 are as follows: 2021 2020 Long-term income tax assets, included in $ 23.9 $ 19.6 Long-term deferred income tax liability ( 6.5 ) ( 5.9 ) Net deferred income tax asset $ 17.4 $ 13.7
Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination	Jurisdiction Open Years U.S. federal 2016 — 2021 China 2012 — 2021 France 2019 — 2021 Germany 2018 — 2021
Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2021, 2020 and 2019 is as follows: 2021 2020 2019 Balance at beginning of year $ 20.1 $ 11.5 $ 12.8 Additions for tax positions of current year 0.1 0.3 0.5 Additions for tax positions of prior years — 10.9 0.3 Reductions for tax positions of prior years ( 0.2 ) ( 0.4 ) — Reductions based on settlements with tax ( 0.2 ) ( 2.1 ) ( 0.6 ) Reductions for lapse of statute of limitations ( 1.4 ) ( 0.1 ) ( 1.5 ) Balance at end of year $ 18.4 $ 20.1 $ 11.5

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Reconciliation of the weighted average shares outstanding used to compute basic and diluted earnings per share	The following is a reconciliation of the weighted average common shares outstanding used to compute basic and diluted net income (loss) per share: 2021 2020 2019 Basic weighted average common shares outstanding 34,903,189 34,691,063 35,487,358 Effect of dilutive securities - stock awards 549,366 — 154,442 Diluted weighted average common shares outstanding 35,452,555 34,691,063 35,641,800

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of Components of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss as of December 31, 2021 and 2020 are as follows: 2021 2020 Foreign currency translation, net of income tax (provision) 0.6 and $( 4.6 ) $ ( 70.1 ) $ ( 49.6 ) Employee pension and postretirement benefit adjustments, 13.9 and $ 14.4 ( 32.3 ) ( 47.9 ) Total accumulated other comprehensive loss $ ( 102.4 ) $ ( 97.5 ) A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component as of December 31, 2020 and 2021 are as follows: Gains Pension & Foreign Total Balance as of December 31, 2019 $ — $ ( 39.9 ) $ ( 81.1 ) $ ( 121.0 ) Other comprehensive income (loss) before ( 0.3 ) ( 9.9 ) 31.5 21.3 Amounts reclassified from accumulated other 0.3 1.9 — 2.2 Net other comprehensive income (loss) — ( 8.0 ) 31.5 23.5 Balance as of December 31, 2020 — ( 47.9 ) ( 49.6 ) ( 97.5 ) Other comprehensive income (loss) before ( 1.1 ) 14.5 ( 20.5 ) ( 7.1 ) Amounts reclassified from accumulated other 1.1 1.1 — 2.2 Net other comprehensive income (loss) — 15.6 ( 20.5 ) ( 4.9 ) Balance as of December 31, 2021 $ — $ ( 32.3 ) $ ( 70.1 ) $ ( 102.4 )
Reconciliation of reclassifications out of accumulated other comprehensive income (loss), net of income taxes	A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2021, 2020 and 2019 are as follows: Amount Reclassified from Accumulated Other Comprehensive Loss 2021 2020 2019 Recognized Losses on cash flow hedges FX Forward Contracts $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Cost of sales Total before income taxes ( 1.1 ) ( 0.3 ) ( 3.1 ) Provision for income taxes — — — Total, net of income taxes $ ( 1.1 ) $ ( 0.3 ) $ ( 3.1 ) Amortization of pension and Actuarial losses $ ( 4.7 ) $ ( 4.5 ) $ ( 4.6 ) (a) Other expense - net Amortization of prior service cost 2.6 2.6 2.8 (a) Other expense - net Pension settlement charge 0.9 — — (a) Other expense - net Total before income taxes ( 1.2 ) ( 1.9 ) ( 1.8 ) Benefit for income taxes 0.1 — — Total, net of income taxes $ ( 1.1 ) $ ( 1.9 ) $ ( 1.8 ) Total reclassifications for the period, net $ ( 2.2 ) $ ( 2.2 ) $ ( 4.9 ) (a) These accumulated other comprehensive loss components are components of net periodic pension cost (see Note 22, “Employee Benefit Plans,” for further details).

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of the Company's Stock Option Activity	A summary of the Company’s stock option activity is as follows: Shares Weighted Aggregate Options outstanding as of December 31, 2020 1,067,880 $ 20.91 Granted — — Exercised ( 306,015 ) 19.50 Forfeited ( 1,327 ) 18.40 Cancelled ( 135,221 ) 24.79 Options outstanding as of December 31, 2021 625,317 $ 20.76 $ 1.0 Options exercisable as of December 31, 2021 509,911 $ 22.22 $ 0.5
Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant	T he fair value of each option grant was estimated at the date of grant using the following assumptions: 2020 2019 Expected life (years) 6.5 6.5 Risk-free interest rate 1.2 % 2.6 % Expected volatility 42.3 % 39.8 % Expected dividend yield — % — %
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Share Activity	A summary of activity for restricted stock units is as follows: Shares Weighted Unvested as of December 31, 2020 362,293 $ 14.87 Granted 358,255 17.59 Vested ( 154,099 ) 17.36 Forfeited ( 14,793 ) 16.98 Unvested as of December 31, 2021 551,656 $ 15.89
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant	The fair value of each total shareholder return performance share unit was estimated at the date of grant using the following assumptions: 2021 2020 2019 Correlation 27.9 % 32.2 % 32.5 % Risk-free interest rate 0.2 % 1.1 % 2.5 % Expected volatility 59.0 % 47.5 % 47.0 % Expected dividend yield — % — % — %
Schedule of Nonvested Share Activity	A summary of activity for performance share units is as follows: Shares Weighted Unvested as of December 31, 2020 358,335 $ 18.64 Granted 159,247 18.92 Vested ( 5,825 ) 17.50 Forfeited ( 11,073 ) 17.25 Unvested as of December 31, 2021 500,684 $ 17.45

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Schedule of Information by Reportable Segment	The following table shows information by reportable segment for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Net Sales Americas $ 757.6 $ 626.1 $ 969.7 EURAF 677.0 598.7 644.9 MEAP 285.6 218.6 219.5 Total $ 1,720.2 $ 1,443.4 $ 1,834.1 Segment Operating Income Americas $ 57.3 $ 32.1 $ 113.4 EURAF 8.9 12.0 3.8 MEAP 30.9 30.4 22.6 Total $ 97.1 $ 74.5 $ 139.8 Depreciation Americas $ 20.7 $ 15.7 $ 14.5 EURAF 19.8 16.5 15.1 MEAP 2.1 2.1 2.4 Corporate 2.9 2.9 3.0 Total $ 45.5 $ 37.2 $ 35.0 Capital Expenditures Americas $ 11.3 $ 6.0 $ 13.2 EURAF 27.5 19.0 19.0 MEAP 1.5 1.2 2.9 Corporate 0.1 0.1 — Total $ 40.4 $ 26.3 $ 35.1
Schedule of Reconciliation of the Company's Segment Operating Income (Loss)	A reconciliation of the Company’s segment operating income to operating income in the Consolidated Statement of Operations for the years ended December 31, 2021, 2020 and 2019 is as follows: 2021 2020 2019 Segment operating income $ 97.1 $ 74.5 $ 139.8 Unallocated corporate expenses ( 51.1 ) ( 32.2 ) ( 31.3 ) Unallocated restructuring income (expense) 0.5 ( 3.7 ) ( 0.1 ) Total operating income $ 46.5 $ 38.6 $ 108.4
Schedule of Net Sales and Property, Plant and Equipment by Geographic Area	Net sales by geographic area for the years ended December 31, 2021, 2020 and 2019 and property, plant and equipment as of December 31, 2021 and 2020 are summarized as follows: Net Sales Property, Plant and Equipment 2021 2020 2019 2021 2020 United States $ 664.5 $ 564.9 $ 860.4 $ 163.3 $ 97.9 Europe 653.7 585.4 619.8 168.0 167.8 Other 402.0 293.1 353.9 27.5 28.6 Total $ 1,720.2 $ 1,443.4 $ 1,834.1 $ 358.8 $ 294.3
Schedule of Net Sales By Product	Net sales by product for the years ended December 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 New equipment sales $ 1,271.6 $ 1,067.1 $ 1,431.0 Non-new machine sales 448.6 376.3 403.1 Total net sales $ 1,720.2 $ 1,443.4 $ 1,834.1

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
	Dec. 31, 2021
Guarantees [Abstract]
Summary of Warranty Activity	Below is a table summarizing the warranty activity for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Balance at beginning of period $ 63.2 $ 60.6 $ 47.8 Accruals for warranties issued during the 30.4 33.9 47.3 Settlements made (in cash or in kind) during ( 31.3 ) ( 33.6 ) ( 34.2 ) Currency translation ( 2.1 ) 2.3 ( 0.3 ) Balance at end of period $ 60.2 $ 63.2 $ 60.6

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Summary of all restructuring activities	The following is a summary of the Company's restructuring activities for the years ended December 31, 2021, 2020 and 2019: 2021 2020 2019 Balance at beginning of period $ 5.3 $ 2.0 $ 3.3 Restructuring (income) expense* ( 1.1 ) 9.5 9.8 Use of reserve ( 2.7 ) ( 6.2 ) ( 10.9 ) Reserve reclassification — — ( 0.2 ) Currency translation 0.1 — — Balance at end of period $ 1.6 $ 5.3 $ 2.0 *Restructuring expense within the rollforward excludes income related to the forfeiture of equity compensation awards associated with employee separation agreements which was recorded directly to restructuring expense in the Consolidated Statement of Operations and, therefore, did not impact the restructuring accrual.

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Schedule of Components of Period Benefit Costs	The components of periodic benefit costs for the years ended December 31, 2021, 2020 and 2019 are as follows: US Pension Plans Non-US Pension Plans Postretirement Medical 2021 2020 2019 2021 2020 2019 2021 2020 2019 Service cost - benefits earned $ — $ — $ — $ 2.3 $ 2.1 $ 1.8 $ 0.1 $ 0.2 $ 0.2 Interest cost of projected 2.8 4.0 5.1 1.5 1.8 2.2 0.2 0.4 0.8 Expected return on assets ( 4.9 ) ( 5.2 ) ( 4.3 ) ( 1.0 ) ( 1.1 ) ( 1.4 ) — — — Amortization of prior service — — — 0.1 0.1 0.1 ( 2.7 ) ( 2.7 ) ( 2.8 ) Amortization of actuarial net 3.2 2.8 3.3 1.8 1.7 1.3 ( 0.3 ) — — Pension settlement charge — — — ( 0.9 ) — — — — — Net periodic benefit cost $ 1.1 $ 1.6 $ 4.1 $ 3.8 $ 4.6 $ 4.0 $ ( 2.7 ) $ ( 2.1 ) $ ( 1.8 ) Weighted average Effective discount rate for 2.4 % 3.3 % 4.3 % 1.2 % 1.6 % 2.5 % 2.0 % 2.9 % 4.1 % Effective interest rate on 2.0 % 2.9 % 4.0 % 1.2 % 1.6 % 2.5 % 1.3 % 2.6 % 3.7 % Expected return on 4.3 % 5.2 % 5.2 % 1.6 % 2.3 % 3.5 % N/A N/A N/A Rate of compensation N/A N/A N/A 4.1 % 3.1 % 3.6 % N/A N/A N/A
Reconciliation of the Changes in Benefit Obligation, the Changes in Plan Assets, and the Funded Status	The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2021 and 2020: US Pension Plans Non-US Pension Plans Postretirement 2021 2020 2021 2020 2021 2020 Change in Benefit Obligation Benefit obligation, beginning of year $ 151.9 $ 142.3 $ 104.9 $ 90.6 $ 15.8 $ 18.4 Service cost — — 2.3 2.1 0.1 0.2 Interest cost 2.8 4.0 1.5 1.8 0.2 0.4 Participant contributions — — — — 0.3 0.3 Plan curtailment — — ( 0.3 ) ( 0.1 ) — — Actuarial (gain) loss ( 5.4 ) 13.4 ( 3.7 ) 9.7 ( 1.0 ) ( 1.3 ) Currency translation adjustment — — ( 4.2 ) 5.3 — — Pension settlement — — ( 1.9 ) — — — Benefits paid ( 8.1 ) ( 7.8 ) ( 4.1 ) ( 4.5 ) ( 1.7 ) ( 2.2 ) Benefit obligation, end of year $ 141.2 $ 151.9 $ 94.5 $ 104.9 $ 13.7 $ 15.8 Change in Plan Assets Fair value of plan assets, beginning of year $ 113.7 $ 99.6 $ 52.3 $ 45.2 $ — $ — Actual return on plan assets 8.5 12.7 0.6 6.0 — — Employer contributions 0.5 9.2 3.9 3.9 1.4 1.9 Participant contributions — — — — 0.3 0.3 Currency translation adjustment — — ( 0.6 ) 1.7 — — Pension settlement — — ( 1.9 ) — — — Benefits paid ( 8.1 ) ( 7.8 ) ( 4.1 ) ( 4.5 ) ( 1.7 ) ( 2.2 ) Fair value of plan assets, end of year 114.6 113.7 50.2 52.3 — — Funded status $ ( 26.6 ) $ ( 38.2 ) $ ( 44.3 ) $ ( 52.6 ) $ ( 13.7 ) $ ( 15.8 ) Amounts recognized in the Consolidated Short-term pension obligation $ ( 0.5 ) $ ( 0.5 ) $ ( 1.0 ) $ ( 1.1 ) $ — $ — Long-term pension obligation ( 26.1 ) ( 37.7 ) ( 43.3 ) ( 51.5 ) — — Short-term postretirement medical and other — — — — ( 1.6 ) ( 1.8 ) Long-term postretirement medical and other — — — — ( 12.1 ) ( 14.0 ) Net amount recognized $ ( 26.6 ) $ ( 38.2 ) $ ( 44.3 ) $ ( 52.6 ) $ ( 13.7 ) $ ( 15.8 ) Weighted-Average Assumptions Discount rate 2.8 % 2.4 % 1.4 % 1.1 % 2.5 % 2.0 % Expected return on plan assets 4.3 % 5.2 % 1.6 % 2.3 % N/A N/A Rate of compensation increase N/A N/A 4.1 % 3.1 % N/A N/A
Amounts Recognized in Accumulated Other Comprehensive Loss	Amounts recognized in accumulated other comprehensive loss as of December 31, 2021 and 2020, are summarized as follows: Pensions Postretirement 2021 2020 2021 2020 Net actuarial gain (loss) $ ( 51.3 ) $ ( 69.3 ) $ 4.0 $ 3.3 Prior service credit (cost) ( 0.4 ) ( 0.4 ) 1.4 4.1 Total amount recognized $ ( 51.7 ) $ ( 69.7 ) $ 5.4 $ 7.4
Summary of the Sensitivity of Retirement Obligations and Retirement Benefit Costs of Plans to Changes in the Key Assumptions	The following table summarizes the sensitivity of our December 31, 2021 retirement obligations and 2022 retirement benefit costs of our plans to changes in the key assumptions used to determine those results: Change in assumption: Estimated Estimated Estimated increase Estimated 0.50% increase in discount rate $ ( 1.0 ) $ ( 14.2 ) N/A $ ( 0.4 ) 0.50% decrease in discount rate 1.1 15.8 N/A 0.4 0.50% increase in long-term return on assets ( 0.8 ) N/A N/A N/A 0.50% decrease in long-term return on assets 0.8 N/A N/A N/A 1.0% increase in medical trend rates N/A N/A 0.1 0.4 1.0% decrease in medical trend rates N/A N/A ( 0.1 ) ( 0.4 )
Schedule of the Weighted-Average Asset Allocations of the Pension Plans	The weighted-average asset allocations of the U.S. pension plans as of December 31, 2021 and 2020, by asset category are as follows: 2021 2020 Equity 52.7 % 53.3 % Fixed income 38.2 % 38.8 % Other 9.1 % 7.9 % Total 100.0 % 100.0 % The weighted-average asset allocations of the Non-U.S. pension plans as of December 31, 2021 and 2020, by asset category are as follows: 2021 2020 Equity 0.0 % 0.0 % Fixed income 41.3 % 45.6 % Other* 58.7 % 54.4 % Total 100.0 % 100.0 % *Includes diversified investments that have equity and
Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class	The actual and target allocations for the pension assets as of December 31, 2021, by asset class, are as follows: Target Allocations Weighted Average Asset U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Equity Securities 50 % 0 % 52.7 % 0.0 % Debt Securities 40 % 40 % 38.2 % 41.3 % Other 10 % 60 % 9.1 % 58.7 %
Schedule of Plan Assets Using the Fair Value Hierarchy	The following table presents the Company’s plan assets using the fair value hierarchy as of December 31, 2021 and 2020. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. See Note 5, “Fair Value of Financial Instruments,” for definitions of each fair value level. December 31, 2021 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 32.7 $ 32.7 International equity — — — 31.9 31.9 Fixed income: Corporate bonds and notes — — — 27.1 27.1 Government and agency bonds — — — 34.7 34.7 Commingled funds — — — 18.9 18.9 International fixed income — — — 2.2 2.2 Other: Cash and cash equivalents 0.7 — — — 0.7 Money market funds — 0.7 — — 0.7 Annuity contracts — — 12.6 — 12.6 Other — — — 3.3 3.3 Total $ 0.7 $ 0.7 $ 12.6 $ 150.8 $ 164.8 * Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. December 31, 2020 Assets Quoted Significant Unobservable Net Asset Value ("NAV")* Total Equity: U.S. equity $ — $ — $ — $ 32.3 $ 32.3 International equity — — — 30.6 30.6 Fixed income: Corporate bonds and notes — — — 35.7 35.7 Government and agency bonds — — — 30.1 30.1 Commingled funds — — — 17.8 17.8 International fixed income — — — 0.5 0.5 Other: Cash and cash equivalents 0.6 — — — 0.6 Money market funds — 0.7 — — 0.7 Annuity contracts — — 12.9 — 12.9 Other — — — 4.8 4.8 Total $ 0.6 $ 0.7 $ 12.9 $ 151.8 $ 166.0 *Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy.
Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year	A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows: Insurance Contracts 2021 2020 Beginning Balance $ 12.9 $ 12.6 Actual return on assets 0.7 0.9 Benefit payments ( 0.9 ) ( 1.0 ) Foreign currency impact ( 0.1 ) 0.4 Ending Balance $ 12.6 $ 12.9
Schedule of Projected Future Benefit Payments from the Plans	Projected future benefit payments from the plans as of December 31, 2021 are estimated as follows: U.S Pension Non-U.S. Postretirement 2022 $ 8.7 $ 2.8 $ 1.6 2023 8.7 3.0 1.5 2024 8.8 3.2 1.4 2025 8.8 3.7 1.3 2026 8.7 3.9 1.2 Thereafter 41.7 22.8 4.6 Total $ 85.4 $ 39.4 $ 11.6
Schedule of Fair Value of Plan Assets for which the Accumulated Benefit Obligation is in Excess of Plan Assets	The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2021 and 2020 is as follows: U.S Pension Plans Non U.S. Pension Plans 2021 2020 2021 2020 Projected benefit obligation $ 141.2 $ 151.9 $ 93.5 $ 104.9 Accumulated benefit obligation 141.2 151.9 89.1 99.3 Fair value of plan assets 114.6 113.7 50.2 52.3

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Summary of Components of Lease Expense	The components of lease expense for the years ended December 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Operating lease cost $ 13.2 $ 13.2 $ 14.4 Variable lease cost* 1.5 1.5 1.4 Total lease cost $ 14.7 $ 14.7 $ 15.8 *Includes short-term leases, which are immaterial.
Summary of Supplemental Consolidated Balance Sheet Information Related to Leases	Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2021 and 2020 are summarized as follows: 2021 2020 Operating lease right-of-use assets $ 40.6 $ 37.9 Other liabilities $ 12.3 $ 10.5 Operating lease liabilities 29.2 28.4 Total operating lease liabilities $ 41.5 $ 38.9
Summary of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of December 31, 2021 are summarized as follows: Year 2022 $ 12.2 2023 9.3 2024 6.6 2025 4.2 2026 3.2 Thereafter 8.8 Total lease payments 44.3 Less: imputed interest ( 2.8 ) Present value of lease liabilities $ 41.5

Company and Basis of Presenta_2

Company and Basis of Presentation - Narrative (Details)	12 Months Ended
	Dec. 31, 2021Crane
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Period of providing high-quality, customer-focused products and support services	119 years
Number of cranes serviced	155,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Other Intangible Assets Subject to Amortization (Details)	12 Months Ended
	Dec. 31, 2021
Patents
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	20 years
Customer Relationships | Minimum [Member]
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	12 years
Customer Relationships | Maximum [Member]
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	18 years
Trademarks and Tradenames
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	5 years
Noncompetition agreements
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	5 years
Other Intangibles
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	9 months

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Rollforward of the Allowance for Doubtful Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Balance at beginning of period	$ 8.5	$ 7.9
Bad debt expense		3.6
Use of reserve	(1.3)	(2.7)
Currency translation	0.1	(0.3)
Balance at end of period	$ 7.3	$ 8.5

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Building and Improvements | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	2 years
Building and Improvements | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	43 years
Machinery, Equipment and Tooling | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Machinery, Equipment and Tooling | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	18 years
Furniture and Fixtures | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Furniture and Fixtures | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Computer Hardware and Software | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Computer Hardware and Software | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Rental Cranes | Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Rental Cranes | Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	15 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment — net	$ 358.8	$ 294.3
Research and development costs	29.1	30.6	$ 31.1
Assets Leased to Others
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment — net	$ 119.5	$ 59.9

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Millions	Oct. 01, 2021	Sep. 01, 2021	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Acquisitions				$ 15.1
Acquisition of business				186.2	$ 0	$ 0
Aspen
Business Acquisition [Line Items]
Business acquisition purchase price		$ 50.2
Acquisitions				6.2
Acquisition Reason and Description		The acquisition of Aspen was funded from existing cash resources and expands Manitowoc's direct-to-customer footprint in Iowa, Nebraska and Minnesota with new sales, used sales, parts, service and rentals to a variety of end markets.
HEEquipmentServicesIncMember
Business Acquisition [Line Items]
Business acquisition purchase price	$ 139.1			139.1
Acquisitions				8.9
Net working capital	$ 130			50
Property, Plant and Equipment			$ 13.1	13.1
Rental Fleet				48.2
Acquisition Reason and Description	The H&E crane business operates with ten full-service branch locations under the Company's new wholly owned subsidiary, MGX Equipment Services, LLC ("MGX"), and expands Manitowoc’s ability to provide new sales, used sales, aftermarket parts, service and crane financing options to a variety of end market customers.
Outstanding Balances .	$ 3.2
Revenue				$ 50.6
Revenue net of previously recorded third party sales			$ 7.6
HEEquipmentServicesIncMember | AblRevolverMember
Business Acquisition [Line Items]
Outstanding Amount of Acquisition Funded From Cash And Other Facility	$ 100
ASC 805 | Aspen
Business Acquisition [Line Items]
Acquisitions		$ 6.2
Net working capital		12.9
Property, Plant and Equipment		6
Rental Fleet		19.3
Intangible Assets Amount Included In Purchase Price		5.4
Other Assets		$ 0.4

Business Combinations - Schedul

Business Combinations - Schedule of assets acquired and liabilities based upon their estimated fair value (Details) - USD ($) $ in Millions	Oct. 01, 2021	Sep. 01, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwil			$ 15.1
Aspen [Member]
Business Acquisition [Line Items]
Goodwil			6.2
Total fair value consideration		$ 50.2
Aspen [Member] | Accounting Standards Codification Eight Hundred And Five [Member]
Business Acquisition [Line Items]
Net working capital		12.9
Property, Plant and Equipment		6
Rental Fleet		19.3
Goodwil		$ 6.2
HEEquipmentServicesIncMember
Business Acquisition [Line Items]
Net working capital	$ 130		50
Other Adjustments			5.9
Property, Plant and Equipment			13.1
Rental Fleet			48.2
Goodwil			8.9
Noncompetition agreement intangible			3.8
Customer relationships intangible			15.1
Total fair value consideration	$ 139.1		$ 139.1

Recent Accounting Changes and P

Recent Accounting Changes and Pronouncements - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reduction in beginning retained earnings	$ 227.9	$ 216.9
Reduction in accounts receivable	$ 5.2	$ 37.7	$ 124.2

Net Sales - Schedule of Change

Net Sales - Schedule of Change In Customer Advances Balance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Balance at beginning of period	$ 25.5	$ 25.8
Cash received in advance of satisfying performance obligation	128.4	108
Revenue recognized	(124.5)	(108.5)
Currency translation	(0.7)	0.2
Balance at end of period	$ 28.7	$ 25.5

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Financial assets and liabilities accounted for at fair value on a recurring basis by level within the fair value hierarchy (Details) - Estimate of Fair Value Measurement - Fair Value, Measurements, Recurring - Foreign Currency Exchange Contracts - Accounts Payable and Accrued Expenses $ in Millions	Dec. 31, 2021USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative liabilities, current	$ 0.3
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative liabilities, current	$ 0.3

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Narrative (Details) - Senior Notes Due 2026 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 25, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt instruments at fair value	$ 317.8
Interest rate, stated percentage (as a percent)	9.00%	9.00%
Debt instrument maturity date	Apr. 1, 2026

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Derivatives Fair Value [Line Items]
Net unrealized gain (losses) net of income tax	$ 0	$ 0
Foreign Exchange Forward
Derivatives Fair Value [Line Items]
Derivative, notional amount	$ 11.3	9.3
Derivative remaining maturity period	1 year
Derivative net current liability	$ (0.3)	$ (0.3)

Derivative Financial Instrume_4

Derivative Financial Instruments - Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Designated | Cost of Sales
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ (1.1)	$ (0.3)	$ (3.1)
Non-Designated | Other Income (Expense) - Net
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ 0.4	$ 0.6	$ 3.9

Inventories - Components of Inv

Inventories - Components of Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 157.4	$ 89.6
Work-in-process	140.4	102.3
Finished goods	279	281.2
Inventories — net	$ 576.8	$ 473.1

Notes Receivable - Narrative (D

Notes Receivable - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Notes receivable, current	$ 16.7	$ 13.6
Notes receivable, long term	5.2	$ 12.7
Reserve for the remaining net value of the note	$ 3.6

Property, Plant and Equipment -

Property, Plant and Equipment - Components of property, plant and equipment (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment
Total cost	$ 821.1	$ 756.1
Less accumulated depreciation	(462.3)	(461.8)
Property, plant and equipment — net	358.8	294.3
Land
Property, Plant and Equipment
Total cost	19.4	20.3
Building and Improvements
Property, Plant and Equipment
Total cost	203.4	203.7
Machinery, Equipment and Tooling
Property, Plant and Equipment
Total cost	298.9	292.6
Furniture and Fixtures
Property, Plant and Equipment
Total cost	14.5	21
Computer Hardware and Software
Property, Plant and Equipment
Total cost	125.6	119.3
Rental Cranes
Property, Plant and Equipment
Total cost	144.2	90.2
Property, plant and equipment — net	119.5	59.9
Construction in Progress
Property, Plant and Equipment
Total cost	$ 15.1	$ 9

Property, Plant and Equipment_2

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment
Asset impairment expense	$ 1.9	$ 0	$ 0
Asset impairment expense		0
Other Current Assets
Property, Plant and Equipment
Assets held for sale	$ 3.1	$ 3.3

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Acquisition of business	$ 15.1
Amortization of intangible assets	$ 1.4	$ 0.3	$ 0.3
Noncompetition agreements
Goodwill [Line Items]
Finite-lived intangible asset, useful life	5 years
Other Intangibles
Goodwill [Line Items]
Finite-lived intangible asset, useful life	9 months
Aspen [Member]
Goodwill [Line Items]
Acquisition of business	$ 6.2
weighted average useful life	3 years 2 months 12 days
Aspen [Member] | Customer Relationships
Goodwill [Line Items]
Intangible asset acquired	$ 2.2
Finite-lived intangible asset, useful life	18 years
Aspen [Member] | Trade names
Goodwill [Line Items]
Intangible asset acquired	$ 2.2
Finite-lived intangible asset, useful life	5 years
Aspen [Member] | Noncompetition agreements
Goodwill [Line Items]
Intangible asset acquired	$ 0.2
Finite-lived intangible asset, useful life	5 years
Aspen [Member] | Other Intangibles
Goodwill [Line Items]
Intangible asset acquired	$ 0.8
Finite-lived intangible asset, useful life	9 months
HEEquipmentServicesIncMember
Goodwill [Line Items]
Acquisition of business	$ 8.9
weighted average useful life	9 years 4 months 24 days
HEEquipmentServicesIncMember | Customer Relationships
Goodwill [Line Items]
Intangible asset acquired	$ 15.1
Finite-lived intangible asset, useful life	12 years
HEEquipmentServicesIncMember | Noncompetition agreements
Goodwill [Line Items]
Intangible asset acquired	$ 3.8
Finite-lived intangible asset, useful life	5 years

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Changes in goodwill by reportable segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill
Balance at the beginning of the period	$ 235.1	$ 232.5
Foreign currency impact	(0.5)	2.6
Acquisitions	15.1
Net balance at the end of the period	249.7	235.1
Americas
Goodwill
Balance at the beginning of the period	166.5	166.5
Foreign currency impact	0
Acquisitions	0
Net balance at the end of the period	166.5	166.5
Americas - Distribution
Goodwill
Balance at the beginning of the period	0	0
Foreign currency impact	0
Acquisitions	15.1
Net balance at the end of the period	15.1	0
Middle East and Asia Pacific ("MEAP")
Goodwill
Balance at the beginning of the period	68.6	66
Foreign currency impact	(0.5)	2.6
Acquisitions	0
Net balance at the end of the period	$ 68.1	$ 68.6

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Gross carrying amount and accumulated amortization of the company's intangible assets other than goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	$ 24.8
Intangible assets, gross (excluding goodwill)	178.4	$ 160.5
Finite-lived intangible assets, amortization amount	(38.8)	38.9
Intangible assets, book value	139.6	121.6
Indefinite-lived Intangible Assets
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	114.7	119.6
Intangible assets, book value	114.7
Indefinite-lived Intangible Assets | Distribution Network
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	18.8	19.6
Intangible assets, gross (excluding goodwill)	18.8	19.6
Finite-Lived Intangible Assets
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	63.7	40.9
Finite-lived intangible assets, amortization amount	(38.8)	38.9
Intangible assets, book value	24.9	2
Finite-Lived Intangible Assets | Customer Relationships
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	27	9.9
Intangible assets, gross (excluding goodwill)	18	1.3
Finite-lived intangible assets, amortization amount	(9)	(8.6)
Finite-Lived Intangible Assets | Patents
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	29.7	31
Intangible assets, gross (excluding goodwill)	0.6	0.7
Finite-lived intangible assets, amortization amount	(29.1)	(30.3)
Finite-Lived Intangible Assets | Noncompetition agreements
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	4.2
Intangible assets, gross (excluding goodwill)	3.8
Finite-lived intangible assets, amortization amount	(0.4)
Finite-Lived Intangible Assets | Other Intangibles
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	0.6
Intangible assets, gross (excluding goodwill)	0.4
Finite-lived intangible assets, amortization amount	(0.2)
Trademarks and Tradenames | Indefinite-lived Intangible Assets
Intangible asset balances by major asset class
Indefinite-lived intangible assets, book value	95.9	100
Finite-lived intangible assets, carrying amount		$ 100
Trademarks and Tradenames | Finite-Lived Intangible Assets
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	2.2
Intangible assets, gross (excluding goodwill)	2.1
Finite-lived intangible assets, amortization amount	$ (0.1)

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Estimated Amortization Expense (Details) $ in Millions	Dec. 31, 2021USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 3.3
2023	2.9
2024	2.9
2025	2.9
2026	2.7
Thereafter	10.1
Total	$ 24.8

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Trade accounts payable	$ 238.8	$ 178.1
Employee-related expenses	51.9	38.5
Accrued vacation	22.2	22.4
Miscellaneous accrued expenses	100.5	90.4
Total accounts payable and accrued expenses	$ 413.4	$ 329.4

Debt - Schedule of outstanding

Debt - Schedule of outstanding debt (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total debt	$ 407,200,000	$ 310,900,000
Deferred financing costs	(3,100,000)	(3,800,000)
Short-term borrowings and current portion of long-term debt	(7,300,000)	(10,500,000)
Long-term debt	399,900,000	300,400,000
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing under senior secured asset based revolving credit facility	100,000,000	0
Senior Notes Due 2026
Debt Instrument [Line Items]
Total debt	300,000,000	300,000,000
Other
Debt Instrument [Line Items]
Total debt	$ 10,300,000	$ 14,700,000

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Mar. 25, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt instrument charge from refinancing		$ 0	$ 0	$ 25,000,000
Unamortized debt issuance costs		3,100,000	3,800,000
Carrying amount		$ 407,200,000	310,900,000
Period for which the entity will be able to comply with the financial covenants		12 months
Senior Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt	$ 300,000,000
Debt instrument interest rate	9.00%	9.00%
Interest on the notes		Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year.
Carrying amount		$ 300,000,000	$ 300,000,000
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 275,000,000
Weighted average interest rate (as a percent)		1.40%	1.80%
Line of credit outstanding		$ 100,000,000	$ 0
Highest daily borrowing		100,000,000	50,000,000
Average borrowing		26,000,000	13,300,000
Excess capacity		136,300,000
Line of credit borrowing capacity		$ 239,300,000
ABL Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		1.25%
ABL Revolving Credit Facility | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.25%
ABL Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Debt term (in years)	5 years
ABL Revolving Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 75,000,000
Line of credit outstanding		$ 3,000,000
ABL Revolving Credit Facility | Letter of Credit | German Borrowers
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 10,000,000
Other
Debt Instrument [Line Items]
Carrying amount		$ 10,300,000	$ 14,700,000
Weighted average interest rate (as a percent)		3.40%

Debt - Schedule of Revolving Cr

Debt - Schedule of Revolving Credit Facility Bear Interest at Variable Rate Based Upon Average Quarterly Availability (Details) - ABL Revolving Credit Facility	12 Months Ended
	Dec. 31, 2021
Greater Than or Equal to 50% of Aggregate Commitment | Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.25%
Greater Than or Equal to 50% of Aggregate Commitment | Eurodollar and Overnight LIBOR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.25%
Less Than 50% of Aggregate Commitment | Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.50%
Less Than 50% of Aggregate Commitment | Eurodollar and Overnight LIBOR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.50%

Debt - Schedule of Aggregate Fu

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Details) $ in Millions	Dec. 31, 2021USD ($)
Aggregate scheduled future maturities of outstanding debt obligations
2022	$ 7.3
2023	1.4
2024	101.5
2025	0.1
2026	300
Thereafter	0
Total	$ 410.3

Debt - Schedule of Aggregate _2

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Deferred financing costs	$ 3.1	$ 3.8

Accounts Receivable Factoring -

Accounts Receivable Factoring - Narrative (Details) - 12 months ended Dec. 31, 2021 € in Millions, $ in Millions	EUR (€)	USD ($)
Accounts Receivable Securitization
Accounts receivable balance sold		$ 228.6
Proceeds from collection of receivables		228.6
Maximum availability under these programs	€ 55	$ 40.5

Income Taxes - Summary of Incom

Income Taxes - Summary of Income (Loss) from Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income (loss) from continuing operations before income taxes:
U.S.	$ (39)	$ (51.6)	$ (10)
Non-U.S.	56.1	49.6	69
Income (loss) before income taxes	$ 17.1	$ (2)	$ 59

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
U.S. federal and state	$ (1.2)	$ (4.3)	$ (0.7)
Non-U.S.	7.9	16.6	11.6
Total current	6.7	12.3	10.9
Deferred:
U.S. federal and state	0.6	0.3	0.2
Non-U.S.	(1.2)	4.5	1.3
Total deferred	(0.6)	4.8	1.5
Income tax provision (benefit)	$ 6.1	$ 17.1	$ 12.4

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Operating Loss Carryforwards [Line Items]
Federal income tax at statutory rate (as a percent)	21.00%	21.00%	21.00%
Tax cuts and jobs act of 2017 change in net operating losses and valuation allowance	$ 2.5
Recognized tax benefit	1.6
Change in valuation allowance, deferred tax asset	(6.9)	$ (22.2)	$ (4.5)
Deferred tax assets, valuation allowance	170.5	171.4
Increase in deferred tax assets, valuation allowance	6.9	22.2	4.5
Tax cuts and jobs act, deferred tax assets	0.8	0.9
Tax cuts and jobs act, unremitted earnings of non-United States subsidiaries	245.5	239.4
Tax cuts and jobs act, additional unremitted earnings of non-United States subsidiaries	481.5
U.S. federal income tax at statutory rate	3.6	(0.4)	12.4
Interest expense carryforwards	$ 9
Percentage of tax adjustable	3000.00%
Change to gross unrecognized tax (expense) benefits including interest and penalties	$ (2.1)	5.5	1.7
Uncertain tax liabilities interest and penalties	(0.4)	(3.1)	(0.3)
Uncertain tax liabilities interest and penalties accrued	2.9	3.3	6.4
Unrecognized Tax Benefits	18.4	20.1	11.5	$ 12.8
Unrecognized tax benefits due to the closing of statues of limitations	1.4	0.1	1.5
Unrecognized tax benefits that would impact effective tax rate	14	15.4	7.2
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	189
U.S. federal income tax at statutory rate	1.9
Operating loss carryforwards with specific expiration period	24.4
Operating loss carryforwards without time restrictions for future use	$ 164.6
Operating loss carryforwards expiration period	2036
Maximum annual utilization percentage of indefinite lived loss carryforwards	80.00%
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 772
Operating loss carryforwards expiration period	2041
Non-U.S. Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 281.2
Net operating loss carryforwards, valuation allowance	151.9
Federal Ministry Of Finance Germany
Operating Loss Carryforwards [Line Items]
Non US Income Tax Audit Rate	0.8
China
Operating Loss Carryforwards [Line Items]
Deferred tax assets, valuation allowance	2.7
Non-U.S.
Operating Loss Carryforwards [Line Items]
Tax cuts and jobs act of 2017 change in net operating losses and valuation allowance		$ 0	$ 22.7
Unrecognized Tax Benefits	$ 1.4

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. federal income tax at statutory rate	$ 3.6	$ (0.4)	$ 12.4
U.S. state income tax provision	0.3	1.9	(0.1)
Manufacturing and research incentives	(0.2)	(0.8)	(3)
Taxes on non-U.S. income which differ from the U.S. statutory rate	1.5		(2.6)
Adjustments for unrecognized tax benefits	(2.3)	10.7	(1.3)
Adjustments for valuation allowances	4.5	22.2	4.5
U.S. tax reform	(1.6)	(14.6)	4
Other items	0.3	(1.9)	(1.5)
Income tax provision (benefit)	$ 6.1	$ 17.1	$ 12.4

Income Taxes - Schedules of Def

Income Taxes - Schedules of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Non-current deferred income tax assets (liabilities):
Inventories	$ 23.9	$ 22.8
Accounts receivable	(1.5)	(2.7)
Property, plant and equipment	(23)	(17.2)
Intangible assets	(34.7)	(36)
Deferred employee benefits	30.8	34.7
Product warranty reserves	8.9	9.3
Product liability reserves	2	2
Tax credits	7.4	7.7
Loss and other tax attribute carryforwards	151.1	142.6
Deferred revenue	2.4	3.9
Other	(20.6)	18
Total deferred income tax assets	247.1	241
Less valuation allowance	(170.5)	(171.4)
Total deferred income tax liabilities	59.2	55.9
Net deferred income tax assets	76.6	69.6
Net deferred income tax assets	17.4	13.7
Components of Deferred Tax Assets and Liabilities [Abstract]
Long-term income tax assets, included in other non-current assets	23.9	19.6
Long-term deferred income tax liability	(6.5)	(5.9)
Net deferred income tax asset	$ 17.4	$ 13.7

Income Taxes - Schedule of Open

Income Taxes - Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination (Details)	12 Months Ended
	Dec. 31, 2021
United States | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2016
United States | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2021
China | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2012
China | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2021
France | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2019
France | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2021
Germany | Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2018
Germany | Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2021

Income Taxes - Reconciliation_2

Income Taxes - Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 20.1	$ 11.5	$ 12.8
Additions for tax positions of current year	0.1	0.3	0.5
Additions for tax positions of prior years	0	10.9	0.3
Reductions for tax positions of prior years	(0.2)	(0.4)	0
Reductions based on settlements with tax authorities	(0.2)	(2.1)	(0.6)
Reductions for lapse of statute of limitations	(1.4)	(0.1)	(1.5)
Balance at end of year	$ 18.4	$ 20.1	$ 11.5

Net Income (Loss) Per Share - R

Net Income (Loss) Per Share - Reconciliation of the weighted average shares outstanding used to compute basic and diluted earnings per share (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Basic weighted average common shares outstanding (in shares)	34,903,189	34,691,063	35,487,358
Effect of dilutive securities - stock awards (in shares)	549,366	0	154,442
Diluted weighted average common shares outstanding (in shares)	35,452,555	34,691,063	35,641,800

Net Income (Loss) Per Share - N

Net Income (Loss) Per Share - Narrative (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2019
Earnings Per Share [Abstract]
Number of anti-dilutive shares excluded from the calculation of diluted earnings per share	358,706	1,527,645

Equity - Narrative (Details)

Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Class Of Stock [Line Items]
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Par value of common stock (in dollars per share)	$ 0.01
Preferred stock, shares authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)	0
Cash dividends declared or paid	$ 0	$ 0	$ 0
Common Stock
Class Of Stock [Line Items]
Stock repurchase program, remaining authorized amount	10.6
Maximum | Common Stock
Class Of Stock [Line Items]
Stock repurchase program, authorized amount	$ 30

Equity - Schedule of Components

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Foreign currency translation, net of income tax provision of $0.6 and $(4.6)	$ (70.1)	$ (49.6)
Employee pension and postretirement benefit adjustments, net of income benefit of $13.9 and $14.4	(32.3)	(47.9)
Total accumulated other comprehensive loss	$ (102.4)	$ (97.5)

Equity - Schedule of Componen_2

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Foreign currency translation, tax provision	$ 0.6	$ (4.6)
Derivative instrument fair market value, tax provision	$ 13.9	$ 14.4

Equity - Reconciliation of accu

Equity - Reconciliation of accumulated other comprehensive loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	$ 643.5
Total other comprehensive income (loss), net of income tax	(4.9)	$ 23.5	$ (4.4)
Ending balance	662.4	643.5
Gains (Losses) on Cash Flow Hedges
Increase (Decrease) in Equity [Roll Forward]
Other comprehensive income (loss) before reclassifications	(1.1)	(0.3)
Amounts reclassified from accumulated other comprehensive income	1.1	0.3
Pension & Postretirement
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(47.9)	(39.9)
Other comprehensive income (loss) before reclassifications	(14.5)	(9.9)
Amounts reclassified from accumulated other comprehensive income	1.1	1.9
Total other comprehensive income (loss), net of income tax	(15.6)	(8)
Ending balance	(32.3)	(47.9)	(39.9)
Foreign Currency Translation
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(49.6)	(81.1)
Other comprehensive income (loss) before reclassifications	(20.5)	31.5
Total other comprehensive income (loss), net of income tax	(20.5)	31.5
Ending balance	(70.1)	(49.6)	(81.1)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(97.5)	(121)
Other comprehensive income (loss) before reclassifications	(7.1)	21.3
Amounts reclassified from accumulated other comprehensive income		2.2
Total other comprehensive income (loss), net of income tax	(4.9)	23.5
Ending balance	$ (102.4)	$ (97.5)	$ (121)

Equity - Reconciliation of Recl

Equity - Reconciliation of Reclassifications Out of Accumulated Other Comprehensive Income (Loss), Net of Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales	$ 1,413	$ 1,188.7	$ 1,490
Total before income taxes	17.1	(2)	59
Income tax benefit (provision)	(6.1)	(17.1)	(12.4)
Net income (loss)	11	(19.1)	46.6
Other expense - net	1	(10)	9.8
Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Net income (loss)	(2.2)	(2.2)	(4.9)
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes	(1.1)	(0.3)	(3.1)
Net income (loss)	(1.1)	(0.3)	(3.1)
Gains and Losses on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Exchange Contracts
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales	(1.1)	(0.3)	(3.1)
Actuarial Losses | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	(4.7)	(4.5)	(4.6)
Amortization of Prior Service Cost | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	2.6	2.6	2.8
Pension Settlement Charge | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net	0.9
Pension & Postretirement | Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes	(1.2)	(1.9)	(1.8)
Income tax benefit (provision)	(0.1)
Net income (loss)	$ (1.1)	$ (1.9)	$ (1.8)

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock-Based Compensation
Share-based compensation, remaining shares available for issuance (in shares)	4,238,315
Stock-based compensation expense (in dollars)		$ 6
Director
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 1	$ 1	$ 1
Number of share options granted during the period (in shares)	59,280	77,608	673
Engineering Selling and Administrative Expenses
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 7.1	$ 8.5	$ 9.5
Restricted Stock | Restructuring Charges
Stock-Based Compensation
Stock-based compensation expense (in dollars)		2.5
Stock Options
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 0.6	$ 1.3	$ 2.7
Number of share options granted during the period (in shares)	0	250,432	210,243
Weighted average grant date fair value, options (in dollars per share)		$ 5.35	$ 8.07
Unrecognized compensation expense before income tax (in dollars)	$ 0.2
Recognition period for unrecognized compensation expense (in years)	1 year
Stock Options | Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Expiration period (in years)	10 years
Number of share options granted during the period (in shares)	0
Restricted Stock Units
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 3.7	$ 3.5	$ 2.4
Unrecognized compensation expense before income tax (in dollars)	$ 4.8
Recognition period for unrecognized compensation expense (in years)	2 years
Number of shares of other than options granted during the period (in shares)	358,255	333,269	178,371
Restricted Stock Units | Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Options vesting percentage	100.00%
Vesting rights, annual increments beginning on the grant date	100% on the third anniversary of the grant date
Anniversary period from grant date, for grants made prior to 2019 (in years)	3 years
Performance Shares
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 1.9	$ 0.2	$ 3.4
Unrecognized compensation expense before income tax (in dollars)	$ 3
Recognition period for unrecognized compensation expense (in years)	2 years
Number of shares of other than options granted during the period (in shares)	159,247	328,310	228,037
Performance period (in years)	3 years
Period of U.S. Treasury rates as a basis for assumed risk-free rates (in years)	3 years
2013 Omnibus Plan
Stock-Based Compensation
Share-based compensation, shares authorized (in shares)	7,477,395
Performance Shares 2021 | Performance Shares
Stock-Based Compensation
Performance period (in years)	3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)	60.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)	40.00%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group	20.00%
Performance Shares 2020 | Performance Shares
Stock-Based Compensation
Performance period (in years)		3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)	200.00%
Increase decrease in percentage of shares paid based on total shareholder return relative to defined peer group		20.00%
Percentage of shares of other than options granted during the period		200.00%
Performance Shares 2020 | Performance Shares | Minimum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)		0
Performance Shares 2019 | Performance Shares
Stock-Based Compensation
Performance period (in years)	3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)	50.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)	50.00%
Performance Shares 2019 | Performance Shares | Minimum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)	0

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of the Company's Stock Option Activity (Details) - Stock Options - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Shares
Options outstanding at the beginning of the period (in shares)	1,067,880
Granted (in shares)	0	250,432	210,243
Exercised (in shares)	(306,015)
Forfeited (in shares)	(1,327)
Canceled (in shares)	(135,221)
Options outstanding at the end of the period (in shares)	625,317	1,067,880
Options exercisable (in shares)	509,911
Weighted Average Exercise Price Per Share
Options outstanding at the beginning of the period (in dollars per share)	$ 20.91
Granted (in dollars per share)	0
Exercised (in dollars per share)	19.50
Options forfeited weighted average cost (in dollars per share)	18.40
Options canceled weighted average cost (in dollars per share)	24.79
Options outstanding at the end of the period (in dollars per share)	20.76	$ 20.91
Options exercisable (in dollars per share)	$ 22.22
Aggregate Intrinsic Value
Options outstanding (in dollars)	$ 1
Options exercisable (in dollars)	$ 0.5

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock Options
Assumptions used to estimate the fair value of each option grant
Expected life (years)		6 years 6 months	6 years 6 months
Risk-free Interest rate (as a percent)		1.20%	2.60%
Expected volatility (as a percent)		42.30%	39.80%
Performance Shares
Assumptions used to estimate the fair value of each option grant
Correlation (as a percent)	27.90%	32.20%	32.50%
Risk-free Interest rate (as a percent)	0.20%	1.10%	2.50%
Expected volatility (as a percent)	59.00%	47.50%	47.00%

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Nonvested Share Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restricted Stock Units
Shares
Unvested beginning balance (in shares)	362,293
Granted (in shares)	358,255	333,269	178,371
Vested (in shares)	(154,099)
Forfeited (in shares)	(14,793)
Unvested ending balance (in shares)	551,656	362,293
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value beginning (in dollars per share)	$ 14.87
Granted (in dollars per share)	17.59
Vested (in dollars per share)	17.36
Cancelled (in dollars per share)	16.98
Weighted average grant date fair value ending (in dollars per share)	$ 15.89	$ 14.87
Performance Shares
Shares
Unvested beginning balance (in shares)	358,335
Granted (in shares)	159,247	328,310	228,037
Vested (in shares)	(5,825)
Forfeited (in shares)	(11,073)
Unvested ending balance (in shares)	500,684	358,335
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value beginning (in dollars per share)	$ 18.64
Granted (in dollars per share)	18.92
Vested (in dollars per share)	17.50
Cancelled (in dollars per share)	17.25
Weighted average grant date fair value ending (in dollars per share)	$ 17.45	$ 18.64

Segments - Narrative (Details)

Segments - Narrative (Details)	12 Months Ended
	Dec. 31, 2021Segment
Segment Reporting [Abstract]
Number of reportable segments	3

Segments - Schedule of Informat

Segments - Schedule of Information by Reportable Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 1,720.2	$ 1,443.4	$ 1,834.1
Operating (loss) income	46.5	38.6	108.4
Depreciation	45.5	37.2	35
Capital Expenditures	40.4	26.3	35.1
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating (loss) income	(97.1)	74.5	139.8
Operating Segments [Member] | Americas
Segment Reporting Information [Line Items]
Net sales	757.6	626.1	969.7
Operating (loss) income	(57.3)	32.1	113.4
Depreciation	20.7	15.7	14.5
Capital Expenditures	11.3	6	13.2
Operating Segments [Member] | EURAF
Segment Reporting Information [Line Items]
Net sales	677	598.7	644.9
Operating (loss) income	8.9	12	3.8
Depreciation	19.8	16.5	15.1
Capital Expenditures	27.5	19	19
Operating Segments [Member] | Middle East and Asia Pacific ("MEAP")
Segment Reporting Information [Line Items]
Net sales	285.6	218.6	219.5
Operating (loss) income	30.9	30.4	22.6
Depreciation	2.1	2.1	2.4
Capital Expenditures	1.5	1.2	2.9
Corporate
Segment Reporting Information [Line Items]
Operating (loss) income	(51.1)	(32.2)	(31.3)
Depreciation	2.9	2.9	3
Capital Expenditures	$ 0.1	$ 0.1	$ 0

Segments - Schedule of Reconcil

Segments - Schedule of Reconciliation of the Company's Segment Operating Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	$ 46.5	$ 38.6	$ 108.4
Unallocated restructuring expense	(1.1)	7	9.8
Operating Segments [Member]
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	(97.1)	74.5	139.8
Corporate
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	(51.1)	(32.2)	(31.3)
Reconciliation of Company's Segment Operating Income
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	46.5	38.6	108.4
Unallocated restructuring expense	$ 0.5	$ (3.7)	$ (0.1)

Segments - Schedule of Net Sale

Segments - Schedule of Net Sales and Property, Plant and Equipment by Geographic Area (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 1,720.2	$ 1,443.4	$ 1,834.1
Property, Plant and Equipment	358.8	294.3
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	664.5	564.9	860.4
Property, Plant and Equipment	163.3	97.9
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	653.7	585.4	619.8
Property, Plant and Equipment	168	167.8
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	402	293.1	$ 353.9
Property, Plant and Equipment	$ 27.5	$ 28.6

Segments - Schedule of Net Sa_2

Segments - Schedule of Net Sales By Product (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Product Information [Line Items]
Total net sales	$ 1,720.2	$ 1,443.4	$ 1,834.1
New Equipment Sales [Member]
Product Information [Line Items]
Total net sales	1,271.6	1,067.1	1,431
Non New Machine Sales [Member]
Product Information [Line Items]
Total net sales	$ 448.6	$ 376.3	$ 403.1

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Commitments And Contingencies [Line Items]
Period over which product liability self-insurance retention levels have fluctuated (in years)		10 years
Product liability reserves	$ 9,000,000	$ 9,000,000	$ 9,200,000
Warranty claims reserves	60,200,000	60,200,000	63,200,000
Self-insured retention		100,000
Engineering, selling and administrative expenses	13,900,000	258,500,000	$ 208,800,000	$ 225,600,000
Liabilities	14,900,000	14,900,000
Statutory maximum penalties		174,000,000
Maximum
Commitments And Contingencies [Line Items]
Product liability self-insurance maximum retention level for new occurrence	$ 3,000,000	$ 3,000,000

Guarantees - Narrative (Details

Guarantees - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Product Warranty Liability [Line Items]
Revenue deferred related to buyback obligations included in other current and non-current liabilities	$ 31	$ 35.9
Amount of residual value buyback commitments and given by the company	36.4	31.7
Amount of loss guarantees with maximum liabilities	15.8	31.8
Revenue deferred related to extended warranties included in other current and non-current liabilities	$ 7	6.2
Standard product warranties, low end of range (in months)	12 months
Standard product warranties, high end of range (in months)	60 months
Other Noncurrent Liabilities
Product Warranty Liability [Line Items]
Revenue deferred related to extended warranties included in other current and non-current liabilities	$ 11.2	$ 13

Guarantees - Summary of Warrant

Guarantees - Summary of Warranty Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Warranty activity
Balance at beginning of period	$ 63.2	$ 60.6	$ 47.8
Accruals for warranties issued during the period	30.4	33.9	47.3
Settlements made (in cash or in kind) during the period	(31.3)	(33.6)	(34.2)
Currency translation	(2.1)	2.3	(0.3)
Balance at end of period	$ 60.2	$ 63.2	$ 60.6

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring (income) expense	$ (1.1)	$ 7	$ 9.8
Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Stock-based compensation (income) expense (in dollars)		2.5
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring (income) expense	$ 0
Tansfer of Crawler Production to Shady Grove, PA
Restructuring Cost and Reserve [Line Items]
Restructuring (income) expense		$ 2.2
Closure of Manitowoc, WI Facility
Restructuring Cost and Reserve [Line Items]
Restructuring (income) expense			$ 0

Restructuring - Summary of all

Restructuring - Summary of all restructuring activities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Summary of all restructuring accrual
Balance at beginning of period	$ 5.3	$ 2	$ 3.3
Restructuring Expense Income	(1.1)	9.5	9.8
Use of reserve	(2.7)	(6.2)	(10.9)
Reserve reclassification	0	0	(0.2)
Currency translation	0.1	0	0
Balance at end of period	$ 1.6	$ 5.3	$ 2

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)Plan	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	$ 5.8	$ 5.9	$ 6.3
Defined contribution plan, Plan name	Manitowoc 401(k) Retirement Plan	Manitowoc 401(k) Retirement Plan	Manitowoc 401(k) Retirement Plan
Amortization of gains and losses in excess of specified percentage (as a percent)	10.00%
Gain (loss) due to settlements on employee benefit plan	$ 0.9
Postretirement Medical and Other
Manitowoc Deferred Compensation Plan
Annual rate of increase in the per capita cost of covered health care benefits assumed for measurement purposes (as a percent)	5.24%
Ultimate health care cost trend rate (as a percent)	4.50%
Estimated future employer contributions	$ 1.6
Gain (loss) due to settlements on employee benefit plan	$ 0	$ 0	$ 0
Deferred Compensation Plan
Manitowoc Deferred Compensation Plan
Number of investment programs | Plan	2
Deferred Compensation Plan | Program A
Manitowoc Deferred Compensation Plan
Program asset	$ 0.2	0.6
Program obligation	0.2	0.6
Deferred Compensation Plan | Program B
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	0.1	0.4	0.5
Program asset	8.9	9
Program obligation	$ 8.9	9
U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Number of defined contribution retirement plans for the employees | Plan	2
Estimated future employer contributions	$ 0.9
Non-U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan	1.6	$ 1.7	$ 1.2
Estimated future employer contributions	$ 3

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Components of Period Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Components of periodic benefit costs
Pension settlement charge	$ (0.9)
United States
Components of periodic benefit costs
Service cost - benefits earned during the year	0	$ 0
Interest cost of projected benefit obligation	$ 2.8	$ 4
Weighted average assumptions:
Expected return on plan assets (as a percent)	4.30%	5.20%
Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 2.3	$ 2.1
Interest cost of projected benefit obligation	$ 1.5	$ 1.8
Weighted average assumptions:
Expected return on plan assets (as a percent)	1.60%	2.30%
Pension Plan | United States
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0	$ 0	$ 0
Interest cost of projected benefit obligation	2.8	4	5.1
Expected return on assets	(4.9)	(5.2)	(4.3)
Amortization of prior service cost	0	0	0
Amortization of actuarial net loss (gain)	3.2	2.8	3.3
Pension settlement charge	0	0	0
Net periodic benefit cost	$ 1.1	$ 1.6	$ 4.1
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	2.40%	3.30%	4.30%
Effective interest rate on benefit obligation (as a percent)	2.00%	2.90%	4.00%
Expected return on plan assets (as a percent)	4.30%	5.20%	5.20%
Pension Plan | Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 2.3	$ 2.1	$ 1.8
Interest cost of projected benefit obligation	1.5	1.8	2.2
Expected return on assets	(1)	(1.1)	(1.4)
Amortization of prior service cost	0.1	0.1	0.1
Amortization of actuarial net loss (gain)	1.8	1.7	1.3
Pension settlement charge	(0.9)	0	0
Net periodic benefit cost	$ 3.8	$ 4.6	$ 4
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	1.20%	1.60%	2.50%
Effective interest rate on benefit obligation (as a percent)	1.20%	1.60%	2.50%
Expected return on plan assets (as a percent)	1.60%	2.30%	3.50%
Rate of compensation increase (as a percent)	4.10%	3.10%	3.60%
Postretirement Medical and Other
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0.1	$ 0.2	$ 0.2
Interest cost of projected benefit obligation	0.2	0.4	0.8
Expected return on assets	0	0	0
Amortization of prior service cost	(2.7)	(2.7)	(2.8)
Amortization of actuarial net loss (gain)	(0.3)	0	0
Pension settlement charge	0	0	0
Net periodic benefit cost	$ (2.7)	$ (2.1)	$ (1.8)
Weighted average assumptions:
Effective discount rate for benefit obligations (as a percent)	2.00%	2.90%	4.10%
Effective interest rate on benefit obligation (as a percent)	1.30%	2.60%	3.70%

Employee Benefit Plans - Reconc

Employee Benefit Plans - Reconciliation of the Changes in Benefit Obligation, Plan Assets, and Funded Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Change in Plan Assets
Fair value of plan assets, beginning of year	$ 166
Fair value of plan assets, end of year	164.8	$ 166
Amounts recognized in the Consolidated Balance Sheets as of December 31
Long-term pension obligation	(69.4)	(89.3)
Long-term postretirement medical and other benefit obligations	(12.1)	(14)
United States
Change in Benefit Obligation
Benefit obligation, beginning of year	151.9	142.3
Service cost	0	0
Interest cost	2.8	4
Participant contributions	0	0
Plan curtailment	0	0
Actuarial (gain) loss	(5.4)	13.4
Currency translation adjustment	0	0
Pension Settlement	0	0
Benefits paid	(8.1)	(7.8)
Benefit obligation, end of year	141.2	151.9	$ 142.3
Change in Plan Assets
Fair value of plan assets, beginning of year	113.7	99.6
Actual return on plan assets	8.5	12.7
Employer contributions	0.5	9.2
Currency translation adjustment	0	0
Pension settlement	0	0
Benefits paid	(8.1)	(7.8)
Fair value of plan assets, end of year	114.6	113.7	99.6
Funded status	(26.6)	(38.2)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Short-term pension obligation	(0.5)	(0.5)
Long-term pension obligation	(26.1)	(37.7)
Short-term postretirement medical and other benefit obligations	0	0
Long-term postretirement medical and other benefit obligations	0	0
Net amount recognized	$ (26.6)	$ (38.2)
Weighted-Average Assumptions
Discount rate	2.80%	2.40%
Expected return on plan assets (as a percent)	4.30%	5.20%
Non-US Pension Plans
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 104.9	$ 90.6
Service cost	2.3	2.1
Interest cost	1.5	1.8
Participant contributions	0	0
Plan curtailment	(0.3)	(0.1)
Actuarial (gain) loss	3.7	9.7
Currency translation adjustment	4.2	5.3
Pension Settlement	(1.9)	0
Benefits paid	(4.1)	(4.5)
Benefit obligation, end of year	94.5	104.9	90.6
Change in Plan Assets
Fair value of plan assets, beginning of year	52.3	45.2
Actual return on plan assets	0.6	6
Employer contributions	3.9	3.9
Currency translation adjustment	(0.6)	1.7
Pension settlement	1.9	0
Benefits paid	(4.1)	(4.5)
Fair value of plan assets, end of year	50.2	52.3	45.2
Funded status	(44.3)	(52.6)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Short-term pension obligation	(1)	(1.1)
Long-term pension obligation	(43.3)	(51.5)
Short-term postretirement medical and other benefit obligations	0	0
Long-term postretirement medical and other benefit obligations	0	0
Net amount recognized	$ (44.3)	$ (52.6)
Weighted-Average Assumptions
Discount rate	1.40%	1.10%
Expected return on plan assets (as a percent)	1.60%	2.30%
Rate of compensation increase	4.10%	3.10%
Postretirement Medical and Other
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 15.8	$ 18.4
Service cost	0.1	0.2	0.2
Interest cost	0.2	0.4	0.8
Participant contributions	0.3	0.3
Plan curtailment	0	0
Actuarial (gain) loss	(1)	(1.3)
Currency translation adjustment	0	0
Pension Settlement	0	0
Benefits paid	(1.7)	(2.2)
Benefit obligation, end of year	13.7	15.8	18.4
Change in Plan Assets
Fair value of plan assets, beginning of year	0	0
Actual return on plan assets	0	0
Employer contributions	1.4	1.9
Participant contributions	0.3	0.3
Currency translation adjustment	0	0
Pension settlement	0	0
Benefits paid	(1.7)	(2.2)
Fair value of plan assets, end of year	0	0	$ 0
Funded status	(13.7)	(15.8)
Amounts recognized in the Consolidated Balance Sheets as of December 31
Short-term pension obligation	0	0
Long-term pension obligation	0	0
Short-term postretirement medical and other benefit obligations	(1.6)	(1.8)
Long-term postretirement medical and other benefit obligations	(12.1)	(14)
Net amount recognized	$ 13.7	$ (15.8)
Weighted-Average Assumptions
Discount rate	2.50%	2.00%

Employee Benefit Plans - Amount

Employee Benefit Plans - Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	$ (51.3)	$ (69.3)
Prior service credit (cost)	(0.4)	(0.4)
Total amount recognized	(51.7)	(69.7)
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	4	3.3
Prior service credit (cost)	1.4	4.1
Total amount recognized	$ 5.4	$ 7.4

Employee Benefit Plans - Summar

Employee Benefit Plans - Summary of the Sensitivity of Retirement Obligations and Retirement Benefit Costs of Plans to Changes in the Key Assumptions (Details) U_pure in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
Estimated increase (decrease) in 2021 pension cost
Defined Benefit Plan Effect Of One Percent Decrease In Discount Rate On Retirement Obligation	$ (0.4)
Pension Plan
Estimated increase (decrease) in 2021 pension cost
0.50% increase in discount rate	(1)
0.50% decrease in discount rate	1.1
0.50% increase in long-term return on assets	(0.8)
0.50% decrease in long-term return on assets	0.8
Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	(14.2)
0.50% decrease in discount rate	$ 15.8
Postretirement Medical and Other
Estimated increase (decrease) in 2021 pension cost
Defined Benefit Plan Effect Of One Percent Increase In Medical Trend Rates On Retirement Benefit Costs In Next Fiscal Year	0.1
Defined Benefit Plan Effect Of One Percent Increase In Discount Rate On Retirement Obligations	0.4
Defined Benefit Plan Effect Of One Percent Decrease In Medical Trend On Retirement Benefit Costs In Next Fiscal Year	(0.1)
Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	$ (0.4)
0.50% decrease in discount rate	$ 0.4

Employee Benefit Plans - Sche_2

Employee Benefit Plans - Schedule of the Weighted-Average Asset Allocations of the Pension Plans (Details)	Dec. 31, 2021	Dec. 31, 2020
United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	100.00%	100.00%
Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	100.00%	100.00%
Equity Securities | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	52.70%	53.30%
Equity Securities | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	0.00%	0.00%
Fixed Income | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	38.20%	38.80%
Fixed Income | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	41.30%	45.60%
Other | United States
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	9.10%	7.90%
Other | Non-US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	58.70%	54.40%

Employee Benefit Plans - Sche_3

Employee Benefit Plans - Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class (Details)	Dec. 31, 2021	Dec. 31, 2020
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)	100.00%	100.00%
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)	100.00%	100.00%
Equity Securities | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	50.00%
Weighted-average asset allocation (as a percent)	52.70%	53.30%
Equity Securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	0.00%
Weighted-average asset allocation (as a percent)	0.00%	0.00%
Debt Securities | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	40.00%
Weighted-average asset allocation (as a percent)	38.20%
Debt Securities | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	40.00%
Weighted-average asset allocation (as a percent)	41.30%
Other | U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	10.00%
Weighted-average asset allocation (as a percent)	9.10%	7.90%
Other | Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	60.00%
Weighted-average asset allocation (as a percent)	58.70%	54.40%

Employee Benefit Plans - Sche_4

Employee Benefit Plans - Schedule of Plan Assets Using the Fair Value Hierarchy (Details) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 164.8	$ 166
Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	150.8	151.8
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.7
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.6
Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		12.6	12.9
U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		32.7	32.3
U.S. equity | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	32.7	32.3
U.S. equity | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
U.S. equity | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
U.S. equity | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		31.9	30.6
International equity | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	31.9	30.6
International equity | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International equity | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		27.1	35.7
Corporate bonds and notes | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	27.1	35.7
Corporate bonds and notes | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Corporate bonds and notes | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		34.7	30.1
Government and agency bonds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	34.7	30.1
Government and agency bonds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Government and agency bonds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		18.9	17.8
Commingled funds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	18.9	17.8
Commingled funds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Commingled funds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2.2	0.5
International fixed income | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	2.2	0.5
International fixed income | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
International fixed income | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.6
Cash and cash equivalents | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Cash and cash equivalents | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Cash and cash equivalents | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.6
Cash and cash equivalents | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Money market funds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.7
Money market funds | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Money market funds | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0.7	0.7
Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Money market funds | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3.3	4.8
Other | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	3.3	4.8
Other | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Other | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Other | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		12.6	12.9	$ 12.6
Insurance Group Annuity Contracts | Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	0	0
Insurance Group Annuity Contracts | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Insurance Group Annuity Contracts | Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 12.6	$ 12.9
[1]	Certain assets that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy.

Employee Benefit Plans - Reco_2

Employee Benefit Plans - Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	$ 166
Fair value of plan assets, end of year	164.8	$ 166
Insurance Group Annuity Contracts
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	$ 12.9	$ 12.6
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]	Fair Value, Inputs, Level 3 [Member]	Fair Value, Inputs, Level 3 [Member]
Actual return on assets	$ 0.7	$ 0.9
Benefit payments	(0.9)	(1)
Foreign currency impact	(0.1)	0.4
Fair value of plan assets, end of year	$ 12.6	$ 12.9
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]	Fair Value, Inputs, Level 3 [Member]	Fair Value, Inputs, Level 3 [Member]

Employee Benefit Plans - Sche_5

Employee Benefit Plans - Schedule of Projected Future Benefit Payments from the Plans (Details) $ in Millions	Dec. 31, 2021USD ($)
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2022	$ 8.7
2023	8.7
2024	8.8
2025	8.8
2026	8.7
Thereafter	41.7
Total	85.4
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2022	2.8
2023	3
2024	3.2
2025	3.7
2026	3.9
Thereafter	22.8
Total	39.4
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
2022	1.6
2023	1.5
2024	1.4
2025	1.3
2026	1.2
Thereafter	4.6
Total	$ 11.6

Employee Benefit Plans - Sche_6

Employee Benefit Plans - Schedule of Fair Value of Plan Assets for Which the Accumulated Benefit Obligation is in Excess of the Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
United States
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 141.2	$ 151.9
Accumulated benefit obligation	141.2	151.9
Fair value of plan assets	114.6	113.7
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	93.5	104.9
Accumulated benefit obligation	89.1	99.3
Fair value of plan assets	$ 50.2	$ 52.3

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Line Items]
Operating leases, existence of option to extend	true
Operating leases, existence of option to terminate	true
Operating leases, termination term	1 year
Cash payment for operating leases	$ 25.1	$ 24.5	$ 27.4
Operating leases, weighted-average remaining lease term	6 years 3 months 18 days	6 years 6 months
Operating leases, weighted-average discount rate	3.80%	3.81%
Maximum
Leases [Line Items]
Operating leases, remaining lease term	22 years
Operating leases, renewal lease term	10 years

Leases - Summary of Components

Leases - Summary of Components of Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease cost	$ 13.2	$ 13.2	$ 14.4
Variable lease cost	1.5	1.5	1.4
Total lease cost	$ 14.7	$ 14.7	$ 15.8

Leases - Summary of Supplementa

Leases - Summary of Supplemental Consolidated Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease right-of-use assets	$ 40.6	$ 37.9
Other liabilities	$ 12.3	$ 10.5
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other liabilities	Other liabilities
Operating lease liabilities	$ 29.2	$ 28.4
Total operating lease liabilities	$ 41.5	$ 38.9

Leases - Summary of Maturities

Leases - Summary of Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2022	$ 12.2
2023	9.3
2024	6.6
2025	4.2
2026	3.2
Thereafter	8.8
Total lease payments	44.3
Less: imputed interest	(2.8)
Present value of lease liabilities	$ 41.5	$ 38.9

Schedule II_ Valuation and Qual

Schedule II: Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Valuation and Qualifying Accounts
Utilization of Reserve	$ 1.3	$ 2.7
Other, Primarily Impact of Foreign Exchange Rates	0.1	(0.3)
Allowance for Doubtful Accounts
Valuation and Qualifying Accounts
Balance at Beginning of Year	8.5	7.9	$ 10.3
Charge to Costs and Expenses	0	3.6	1.4
Utilization of Reserve	(1.3)	(2.7)	(3.9)
Other, Primarily Impact of Foreign Exchange Rates	(0.1)	(0.3)	0.1
Balance at end of Year	7.3	8.5	7.9
Deferred Tax Valuation Allowance
Valuation and Qualifying Accounts
Balance at Beginning of Year	171.4	157.1	153.1
Charge to Costs and Expenses		23.3	11.7
Utilization of Reserve		(1.1)	(7.2)
Other, Primarily Impact of Foreign Exchange Rates		(7.9)	(0.5)
Balance at end of Year	$ 170.5	$ 171.4	$ 157.1